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ABSTRACT 
 
Previous studies in Dr. Yang’s laboratory have established a grafting, design, and 
subdomain approach in order to investigate the properties behind Ca2+-binding sites located in 
Ca2+-binding proteins by employing engineered proteins. These approaches have not only enabled 
us to isolate Ca2+-binding sites and obtain their Ca2+-binding affinities, but also to investigate 
conformational changes and cooperativity effects upon Ca2+ binding.  
The focus of my thesis pertains to optimizing the expression and purification of engineered 
proteins with tailored functions. Proteins were expressed in E. coli using different cell strains, 
vectors, temperatures, and inducer concentrations. After rigorous expression optimization 
procedures, proteins were further purified using chromatographic and/or refolding techniques. 
Expression  and  purification  optimization  of  proteins  is  essential for further analyses,  since  the   
techniques used for these studies require high protein concentrations and purity. Evaluated proteins 
had yields between 5-70 mg/L and purities of 80-90% as confirmed by SDS-PAGE 
electrophoresis.   
INDEX WORDS: Calcium, Engineered proteins, Protein expression, Protein purification, 
Chromatographic techniques. 
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1. INTRODUCTION 
1.1 Ca2+-binding proteins and their properties 
 Calcium (Ca2+) is classified as an alkaline-earth metal and is one of the most abundant 
metallic elements on earth. It is involved in the regulation of numerous important cellular 
signaling pathways and biological processes in living organisms [1, 2]. In the Ca2+-dependent 
signal pathways, Ca2+ binding usually results in large conformational changes which allow 
proteins to interact with downstream partners or other target molecules.  
 Ca2+ concentrations vary more than 1000-fold in intracellular and extracellular 
environments and that is why Ca2+-binding proteins usually have different Ca2+-binding affinities 
depending upon their functional locations [2-4]. These proteins function by experiencing Ca2+ 
induced conformational changes whereby Ca2+ influxes are translated into metabolic responses 
[5]. For example, eukaryotic cells in a resting state can present a cytoplasmic Ca2+ ion level 
between 10-7-10-6 M, which can be considered quite low compared to an extracellular 
concentration of 10-3 M (Figure 1) [4, 6]. It is important to mention that external stimuli such as 
hormonal signals can change the cytoplasmic Ca2+ ion level to an activated state of ~10-6 M [4, 
6]. Thus, a significant number of intracellular and extracellular Ca2+-binding proteins play 
essential roles in maintaining a proper distribution of Ca2+ concentrations [3]. These Ca2+-
binding proteins have important intracellular and extracellular functions. For example, 
intracellular Ca2+-binding proteins are important in Ca2+ buffer and transport systems, activation 
of enzymes, metabolism, gene expression, apoptosis, and Ca2+ storage just to mention a few 
intracellular functions (Figure 1) [2-4]. Additionally, extracellular Ca2+-binding proteins are 
important in neurite extension, chemotactic and hormone activity and they are important 
extracellular matrix components (Figure 1) [2-4].  
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Figure 1. Intracellular and extracellular Ca2+ concentrations and important functions of Ca2+-
binding proteins (CaBPs) [2-4]. 
 For example, calmodulin (CaM) is an extremely important and well studied intracellular 
Ca2+-binding protein that belongs to the large EF-hand family. A typical EF-hand protein 
consists of two or more α–helices oriented ~90o with respect to each other, and a loop around the 
Ca2+ ion in a helix-loop-helix formation [5, 7-9]. CaM contains four EF-hand motifs, and other 
EF-hand proteins may include  two to eight EF-hand motifs [5, 7]. EF-hand proteins usually bind 
3 
to Ca2+ in a pentagonal bipyramidal arrangement with seven oxygen ligands (six of the ligands 
from the protein’s side chains of Asp, Asn, Glu, and/or the main chain, and one from a water 
molecule) [5, 8]. EF-hand proteins have similar primary sequences and secondary structures but 
their cellular functions and the way they respond to Ca2+ are enormously diverse.  
 Non-EF-hand proteins, such as cell adhesion molecules, transmembrane proteins, and 
receptors like the Ca2+-sensing receptor (CaSR) typically do not possess conserved Ca2+-binding 
loops and helices, but they do possess Ca2+-binding sites located at linker regions between 
domains or on extracellular domains [9]. For example,  the CaSR senses extracellular Ca2+ 
concentrations and responds to those changes by modulating multiple intracellular signaling 
pathways through a series of Ca2+-binding sites located in the extracellular domain (ECD) of this 
receptor [10]. This important receptor is expressed in a great number of tissues and it is 
associated with a large number of diseases including hypercalcaemia, hypocalcaemia, 
hypoparathyroidism, and hyperparathyroidism [11]. 
 It is possible to find a great number of  solved structures of Ca2+-binding proteins, but 
many details related to Ca2+-protein interactions and processes in which these special proteins 
achieve their Ca2+-binding affinities are still unknown [8, 9, 12]. Ca2+-binding proteins are 
characterized by having different Ca2+-binding sites that interact with each other as they sense 
Ca2+. Commonly-used experiments and investigations have been performed in order to study the 
total Ca2+ interaction with different proteins. Due to issues with cooperativity, efforts have been 
made to investigate isolated Ca2+-binding sites either by grafting the sites onto scaffold proteins, 
separating domains, or inactivating binding sites, but these approaches, may produce results in 
the tested system that differ significantly from the intact protein, particularly with respect to 
Ca2+-binding affinities [8, 9, 12]. 
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1.2 Creating engineered Ca2+-binding proteins 
 The first step in creating an engineered protein is to study in detail the chemical, 
biological, physical, and structural properties of the potential host protein. Stability of the host 
protein is an important characteristic because the protein must be able to tolerate mutations 
and/or addition of amino acid sequences while retaining its natural conformation and 
biochemical properties.  
 The development of engineered Ca2+-binding proteins by predicting Ca2+-binding sites and 
further designing or grafting them into a host protein can be an excellent way to understand and 
study Ca2+-protein interaction in more detail. However it is important to emphasize that the host  
protein must retain its native structure after the Ca2+-binding site has been designed or grafted 
and that the protein’s environment should not affect the Ca2+-binding properties [12].  
 Domain one of cluster of differentiation (CD2.D1) is a 99 residue long non-Ca2+-binding 
protein that was chosen as the host protein for protein engineering [13, 14]. CD2.D1 exhibits 
several characteristics that make it an attractive scaffold for engineering, including: easy 
expression and purification; maintenance of its native folding state over a wide range of both pH 
(pH 1.0-10.0) and salt concentrations (0-4 M); and previous data for over 40 mutations shown 
not to produce significant deviations from its native fold [13, 14]. Also, well established X-ray 
and NMR structures for human (Figure 2A) and rat CD2 (Figure 2B) have been reported 
allowing biophysical analysis based on those results [15-18]. Therefore, the design of engineered 
Ca2+-binding proteins using this protein is an excellent way to study Ca2+-binding affinity and 
metal and Ca2+ selectivity by integrating Ca2+-binding sites into CD2.D1.  
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Figure 2. Structure of human and rat CD2. (A) Ribbon drawing for human CD2 domains I and II 
[17]. (B) Ribbon drawing for rat CD2 domain 1 [18]. 
1.3 Protein expression: E. coli as a protein producer 
 The bacterium Escherichia coli (E. coli) is the most widely studied prokaryotic organism 
and most commonly used bacterium for protein production in laboratory and industrial scenarios. 
It is a rod-shaped gram-negative bacterium containing a distinct surface layer composed of inner 
and outer phospholipid membranes and a rigid peptidoglycan cell wall between these two layers 
[19, 20]. This biochemical structure allows these gram-negative bacteria to adjust and adapt 
themselves to different environments and especially to temperature changes, since they also have 
the ability to physically change the diameter of their porins located on the cell membrane when 
they sense environmental changes [20]. E. coli has been selected for different studies because it 
is quite easy to grow in the laboratory and because its genetic mechanisms co-evolved along 
with those of mammals. These microorganisms can be grown in the laboratory in liquid rich or 
minimal media doubling in number about every 20-30 minutes depending upon the media 
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nutrients, usually at a temperature of 37 oC, and they can also be grown as colonies on agar 
plates containing nutrient medium and antibiotics to avoid contamination [19, 21].  
 Most bacteria reproduce via an asexual process called binary fission in which each cell 
increases in size and divides into two cells [22]. During this process there is an orderly increase 
in cellular structures and components, replication and segregation of the bacterial DNA, and 
formation of a septum or cross wall which divides the cell into two progeny cells [22]. A 
growing bacterial population doubles at regular intervals in an exponential way; but the 
exponential growth is only part of the bacterial life cycle, and it does not represent the natural 
pattern of growth of bacterial cultures [22].  
Under optimum conditions, bacteria will increase in number until they either deplete the 
nutrients in the medium or accumulate sufficient waste products to inhibit growth. Under these 
conditions of saturation, the cells undergo a physiological change that allows for survival in the 
absence of growth. This state is called stationary phase, where the number of cells in a culture 
increases slowly, if at all. When stationary phase cells are diluted into fresh medium, they 
undergo another physiological change and begin to divide at an exponential rate known as the 
logarithmic or log phase. Most physiological experiments are conducted using rapidly dividing 
log phase cultures. Cell growth can be measured by following the increase in absorption of a 
culture at 600 nm using a spectrophotometer and checking the optical density (OD) at different 
time periods. A culture with an absorbance of 1.0 at 600 nm contains approximately 2 x 108 
cells/mL [22]. 
1.3.1 Factors that affect protein expression 
Several factors may affect protein expression. For instance, selection of a proper cell 
strain is an essential factor that needs to be considered during bacterial transformation and 
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expression.  This is a critical factor because protein expression can be strongly influenced by the 
way these cell strains respond at different expression temperatures and inducer amounts.  
Protein expression in E. coli can follow two paths, where the protein is either expressed 
in a soluble, well-folded form or as inclusion bodies or similar insoluble aggregates (Figure 3). 
These inclusion bodies are usually inactive misfolded proteins that were formed due to over-
expression. [23]. It is important to mention that sometimes certain proteins can be purified from 
inclusion bodies and therefore, inclusion body formation is desired and sometimes the best way 
to obtain pure and functional proteins [24]. 
99
9
9
9
 
Figure 3. E. coli and the production of soluble or insoluble proteins and two strategies to treat 
and/or  prevent inclusion body formation [25].  
Experimental methods can be designed and modified to avoid inclusion bodies formation. 
First, a refolding strategy can be developed where denaturants are used to initially solubilize and 
unfold the protein, followed by removal of the denaturant to allow Domain 1 of cluster of 
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differentiation 2 the protein to refold into the native and active conformation (Figure 3) [25]. 
Another option is to modify the expression conditions in order to obtain soluble proteins. We can 
therefore test various temperatures, cell strains, and/or media conditions without changing the 
target sequence or we can also engineer the target by expressing fragments or making changes to 
the target sequence using fusion technology (Figure 3) [25].  Low expression temperature and 
low induction concentrations usually increases protein’s solubility [25]. For example, 
temperatures around 30 oC activate a great number of E. coli chaperones stabilizing and favoring 
correct folding [23].  
1.3.1.1 Protein expression using different cell strains 
There are a great variety of cell strains that can be used in order to express proteins in E. 
coli.  The most widely used cell strain is BL21 which does not encode Ion, ompT, and ompP 
proteases minimizing protein degradation during purification [19, 26]. There are different strains 
within BL21. For example, BL21(DE3) contains a T7 RNA polymerase gene that is integrated 
into the genome and that is under control of the lacUV5 promoter, which is a lactose analog 
IPTG inducible system.  The difference between BL21(DE3) and BL21(DE3)pLysS is that the 
pLysS strain has a plasmid encoding a T7 lysozyme gene that allows the expression of more 
toxic proteins in greater amounts since that gene is a natural inhibitor of T7 RNA polymerase  
and therefore, protein expression is tightly regulated [27]. Moreover, the cell wall lysis in the 
purification step is greatly enhanced in pLysS strain compared to DE3 because the lysozyme 
comes out and lyses the cells in addition to the method of cell disruption (French press or 
sonication).  
Tuner is another strain that can be used for protein expression. Tuner strains are lacZY 
deletion mutants of BL21 which enable adjustable levels of protein expression throughout all 
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cells in a culture by allowing precise IPTG control [27]. Therefore, IPTG induction can occur in 
a true concentration-dependent fashion that is uniform throughout the culture and the expression 
can be regulated from very low expression levels up to highly induced expression levels [27].  
Rosetta strains are derived from BL21 lacZY and tuner strains but they carry a pRARE 
derived plasmid that encodes several “rare” E. coli tRNA genes that can be encoded by a 
chloramphenicol resistant plasmid [27]. Some of the rare codon genes are AGG/AGA (arginine), 
AUA (isolucine), and CCC (proline) [27]. Therefore, these strains are designed to increase the 
expression of heterologous proteins whose genes encode numerous rare E. coli codons. 
Expression of these proteins can be dramatically increased when the level of rare tRNA is 
increased within the host.  
Origami strains have mutations in both the thioredoxin reductase (trxB) and glutathione 
reductase (gor) genes, which enhance disulfide bond formation in the cytoplasm. These strains 
are selectable on kanamycin, tetracycline, ampicillin, and chloramphenicol. OrigamiB is a 
derivative of origami and tuner strains and it contains trxB and gor mutations and it facilitates a 
precise IPTG control during protein expression [28].  
It is possible that problems associated with low expression, toxicity or protein solubility 
may be mitigated by protein expression optimization using different cell strains. For general 
expression it might be useful to use BL21(DE3) but if we need to work with a toxic protein it 
might be better to utilize BL21(DE3)pLysS. On the other hand, if we are working with an 
insoluble protein tuner(DE3)pLacI might be the best way to express the target protein. Protein’s 
low expression levels might be enhanced by using rosetta(DE3)pLysS or origamiB(DE3)pLysS. 
A brief description and applications of five cell strains are summarized in Table 1 and a more 
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BL21 - lacks of ompT (outer membrane protein T) membrane and cytoplasmic Lon proteases X X X X X X
DE3 - host carries a chromosomal copy of the T7 RNA polymerase gene under control of the 
lacUV5 promoter
X X X X X X
pLysS - provides T7 lysozyme (reduce basal expression of target genes) X X X X
Carries lacIq for overexpression of lac represor protein (suppresses basal expression from 
promoters)
X
Lacks trxB, thioredoxin reductase (facilitates disulfide bond formation in cytoplasm) X X
Lacks gor, glutathione reductase (facilitates disulfide bond formation in cytoplasm) X X
Lacks lacY (providing a homogeneous uptake of IPTG into all cells in the population) X X
Overproduces lacI (suppress basal transcription  of target genes controlled by lac operators) X
Provides tRNAs for mammalian codons that rarely occur in E. coli X X X
Chloramphenicol resistance X X X X X
Kanamycin  resistance X X
Tetracycline resistance X X
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detailed table that was modified from Novagen with the most commonly used cell strains in our 
lab can be observed in Table 2 [28].  
Table 1. Common applications of five E. coli cell strains  
 
Cell Strain Comments
General 
Expression
BL21(DE3) T7-based expression upon IPTG induction. 
Toxic 
Protein
BL21(DE3)
pLysS
The pLysS plasmid produces T7 lysozyme to 
reduce basal level expression of the gene of 
interest. 
Insoluble  
Protein
Tuner(DE3)
pLacI
Contains a mutation in the lac permease (lacZY) 
gene. This enables adjustment of protein 
expression by using different IPTG 
concentrations.
Low 
Expression
Rosetta(DE3)
pLysS
They supply tRNAs rarely used in E. coli
providing a “universal” translation. 
OrigamiB(DE3) 
pLysS
Contains mutations in thioredoxin reductase and 
glutathione reductase genes, which enhances 
disulfide bond formation in the cytoplasm  
Table 2. Description of cell strains employed in this thesis 
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Temperature and inducer concentrations vary between cell strains and protein expression 
can be highly affected by these factors. Protein solubility is actually enhanced when proteins are 
expressed at lower temperatures (30 oC, 25 oC, or lower), because these low temperatures slow 
down cells growth rate during bacterial expression, help to avoid formation of hydrophobic 
interactions, and proteases activity is highly reduced [20, 27]. Additionally, chromophore 
formation of certain proteins is often achieved at low temperatures.  
1.4 Protein purification and its aims 
Purification may be preparative or analytical. The aims in a preparative purification are to 
produce a relatively large quantity of purified proteins for subsequent use. Examples include the 
preparation of commercial products such as enzymes (e.g. lactase), nutritional proteins (e.g. soy 
protein isolate), and certain biopharmaceuticals (e.g. insulin) [29, 30]. The aim in an analytical 
purification is to produce a relatively small amount of protein for a variety of research or 
analytical purposes, including identification, quantification, and studies of the protein's structure, 
post-translational modifications and function [29]. If the protein is present in low amounts, a 
recombinant DNA technology can be used in order to develop cells that will produce large 
quantities of the desired protein, and in that way, create an expression system.  
Additionally, an analytical purification generally utilizes certain protein properties in 
order to separate proteins, and depending on the source, purified proteins used for analytical 
purposes have to be brought into solution by breaking the tissue or cells containing them. There 
are several methods for achieving this including, repeated freezing and thawing, sonication, 
homogenization by high pressure, or permeabilization by organic solvents. The method of choice 
depends on the relative fragility of the protein and the robustness of the cells. After the 
extraction process, soluble proteins can be separated from cell membranes, DNA, and other 
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undesired components by centrifugation. The extraction process removes proteases, which will 
start digesting proteins in solution. If the protein is sensitive to proteolysis, it is usually desirable 
to proceed quickly, and keep the extract cooled to slow down proteolysis. Usually a protein 
purification protocol contains one or more chromatographic steps. The basic procedure in 
chromatography is to move the solution containing the protein through a column packed with 
various materials. Different proteins interact differently with the column material, and can thus 
be separated by the time required to pass the column or the conditions required to elute the 
protein from the column. 
1.4.1 Commonly used purification techniques: separation based on chemistry 
A great number of chromatographic methods for molecules separation involve a chemical 
interaction between the molecules of interest and the separation medium. These chemical 
interactions include dispersion forces, electrostatic dipole interactions, electron-donor acceptor 
forces, and covalent bonds formations. Dispersion force interactions are caused by induced 
dipole-induced dipole interactions and are therefore classified as non-specific interactions. 
Electrostatic dipole interactions are related to orientation of permanent dipoles and/or the 
interaction between a permanent dipole and an induced dipole. Electron donor acceptor 
interactions include overlap of electron clouds, sharing of lone electrons, and the overlap of 
orbitals to form bonds. Covalent bond formation involves a transition from intermolecular to 
intramolecular forces and it is somewhat related to an electron donor-acceptor interaction [29-
31].  
1.4.1.1 Ion exchange chromatography 
Ion exchange chromatography separates compounds according to the nature and degree 
of their ionic charge. The column to be used is selected according to its type and strength of 
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charge. There are two types of ion exchange chromatography. One is cation exchange in which 
the resins have a negative charge and are used to separate positively charged molecules. The 
second one is anion exchange in which the resins have a positive charge and are used to retain 
and separate negatively charged compounds (Figure 4) [29, 32]. Before the separation begins a 
buffer is pumped through the column to equilibrate the opposing charged ions. Upon injection of 
the sample, solute molecules will exchange with the buffer ions as each competes for the binding 
sites on the resin. The length of retention for each solute depends upon the strength of its charge. 
The most weakly charged compounds will elute first, followed by those with successively 
stronger charges. Because of the nature of the separating mechanism, pH, buffer type, buffer 
concentration, and temperature all play important roles in controlling the separation [29, 32]. 
 
Figure 4. The principle of ion exchange chromatography (anion exchange) [32].  
1.4.1.2 Affinity chromatography 
Affinity chromatography is a method of separating biochemical mixtures, based on a 
highly specific biologic interaction, such as that between antigen and antibody, enzyme and 
substrate, or receptor and ligand [31, 33].  This chromatographic technique separates proteins on 
the basis of a reversible interaction between a protein and a specific ligand attached to a 
chromatographic matrix [33]. Therefore, the target protein or molecule is specifically and 
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reversibly bound to a complementary binding substance (affinity ligand) to then be desorbed 
from the stationary phase (Figure 5) [32].  
 
Figure 5. The principle of affinity chromatography [32]. 
This chromatography technique allows purification of proteins that have fusion tags, such 
as glutathione S-transferase (GST), polyhistidine (6x-his), and/or thioredoxin (thx) tags. The 
sample is applied under conditions that favor specific binding. Unbound material is washed 
away, and the bound target protein is recovered by changing conditions to those favoring 
desorption [32, 33]. Desorption is performed specifically using a competitive ligand or by using 
chemicals or conditions that can break bonds between the fusion tags and the target protein. 
Proteins are then collected, dialyzed in the desired buffer, and if necessary further purified using 
other chromatographic techniques.  
1.4.1.3 Hydrophobic interaction chromatography 
This type of technique separates biological macromolecules like proteins based on their 
hydrophobic surface (Figure 6) [32]. Its separation principle is still not well understood since 
most of the protein’s tertiary structure hides the hydrophobic core and exposes the polar 
residues, but some proteins still present hydrophobic areas or patches on the surface [30-33]. 
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This is a very powerful technique that allows the separation of closely related proteins and it can 
accomplish separations that ion-exchange or affinity chromatography can not accomplish.     
Hydrophobic region  
Figure 6. The principle of hydrophobic interaction chromatography [32].   
1.4.1.4 Protein refolding and denaturant agents 
Proteins can form inclusion bodies or inactive aggregates during the expression procedure 
and in some circumstances these inactive aggregates can be useful and advantageous in protein 
purification. The first step in protein purification using a refolding method is to isolate inclusion 
bodies and then use detergents and denaturants, such as urea, arginine, and/or guanidinium ions 
in order to completely unfold the protein (Figure 7). The following steps involve the removal of 
detergents and denaturants using dialysis or dilution strategies in order to slowly refold the 
protein into its native and active conformation. Sometimes, it is also necessary to further utilize 
other chromatographic techniques, such as ion exchange or affinity chromatography in order to 
further purify the protein.  
Urea Arginine Guanidinium ion  
Figure 7. Chemical structures of three commonly used denaturants.  
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This purification technique has its advantages and disadvantages. Some disadvantages are 
that it is time-consuming and there is no guarantee that the proteins will refold to its native 
conformation without losing activity and stability [26]. However, this purification strategy has 
been successfully demonstrated with small proteins, resulting in high yields at a low cost [26]. 
Additionally, insoluble aggregates are often protected against degradation by reducing the ability 
of proteases to damage the proteins. Therefore, protein refolding can be an excellent technique to 
purify proteins that were expressed as insoluble aggregates. 
One of the most commonly used denaturants in protein refolding is urea or carbamide. 
This water-soluble organic compound, which can form up to eight hydrogen bonds (Figure 7)   
[34], has been widely used to solubilize proteins and especially inclusion bodies since it 
hydrogen-bonds to water [35]. The molecular basis for urea’s denaturation abilities is still 
unknown, but it has been suggested that this compound can have a direct or an indirect effect in 
protein’s stability. Thus, urea might be able to weaken protein’s structure and stability by 
disrupting intramolecular hydrogen-bonds upon direct interaction with the protein [36, 37]. Or it 
might also indirectly affect protein’s stability by altering the solvent environment and in that way 
facilitate exposure of hydrophobic residues [37]. An additional possibility that might explain 
urea’s effect in protein’s stability is that this effect might be a combination of protein-urea and 
solvent-urea interaction.  
1.4.2 Detection of impurities using SDS-PAGE electrophoresis 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) is an excellent 
and relatively rapid way to determine a protein’s molecular mass and at the same time analyze its 
purity and expression level since this technique separates proteins according to size [29]. This 
technique has been widely used to optimize purification steps and strategies in order to increase 
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protein’s purity, expression, and stability [29]. The sample to be analyzed is mixed with a 
detergent (SDS) in order to denature the protein’s secondary and tertiary structures, and at the 
same time apply a negative charge to the proteins since SDS is an anionic detergent containing a 
sulfate group. Therefore, proteins will be in a primary structure and they will be negatively 
charged allowing them to migrate toward the positive pole when an electric field is employed. 
Denatured samples will pass through a large pore 4% polyacrylamide gel (stacking gel) in order 
to have a starting point where all the proteins are concentrated to then pass through a small pore 
3-30% polyacrylamide gel (resolving gel) containing different pore sizes and where smaller 
proteins will be able to go further down the gel whereas the larger proteins will stay on the top.     
1.5 Objectives of this study 
The main objectives of this study are to optimize the expression and purification of 
engineered Ca2+-binding proteins. Protein’s expression and purification are essential steps 
necessary to obtain proteins with high purity and yields. The successful optimization of these 
two important steps will allow us to obtain high quality and quantity proteins with the least 
possible amount of time and effort. These proteins will be used to perform future experiments 
(such as, metal binding studies, nuclear magnetic resonance (NMR), mass spectroscopy (MS), 
circular dichroism (CD), and titrations) in order to test their conformation and metal binding 
affinity and selectivity.   
1.6 Overview 
The research in this thesis is organized in the following way: In Chapter 1, I have introduced 
Ca2+-binding proteins and some of their most important properties and functions in extracellular 
and intracellular environments. I have also introduced important concepts related to the 
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expression and purification, such as factors that affect protein expression in E. coli and important 
purification techniques that are commonly used to purify proteins.  
In Chapter 2, materials and methods used to express and purify engineered Ca2+-binding 
proteins are presented. The expression of some of these proteins was performed in two different 
media and four chromatographic techniques were used in order to purify engineered proteins 
depending upon the protein’s physiochemical and conformational characteristics. The remaining 
chapters will focus on the expression and purification of engineered Ca2+-binding proteins that 
were developed using either a grafting, subdomain, and/or design approach.  
Chapter 3 introduces the grafting approach and how two host proteins, CD2 and EGFP, were 
used to insert Ca2+-binding motifs to study metal-binding affinity, selectivity, and the creation of 
new EGFP-based Ca2+ sensors. This chapter presents the expression of CD2-WT and EGFP-WT 
and their variants, and it also includes protein purification using affinity (GST-tag or His-tag) 
and ion exchange chromatography.  
Chapter 4 presents a brief relationship between CaM and the grafting approach. This chapter 
will mainly focus on the expression and purification of this important intracellular Ca2+-binding 
protein.  
Chapter 5 relates the grafting approach with the subdomain approach and how these 
approaches were used in order to study the CaSR and its Ca2+-binding affinity and selectivity. 
This chapter presents the expression and purification of two engineered Ca2+-binding sites that 
were grafted into CD2.D1 and purified using affinity (GST-tag) and ion exchange 
chromatography. It also includes the expression optimization of subdomain 1, 2, and 3 of the 
ECD of the CaSR and their purification employing affinity (6x-his-tag) chromatography for 
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subdomain 1 and 2, and a refolding method for subdomain 3. It will also discuss recent studies 
and accomplishments in the expression and purification of the ECD of the CaSR.  
Chapter 6 introduces the design approach, the expression and purification of tag-less 
proteins CD2.7E15 and a variant using a refolding method and their applications as MRI contrast 
agents. 
Chapter 7 is a concise summary of major conclusions and the significance of this thesis.  
A summary of all studied engineered proteins by chapter and information related to their 
expression and purification can be observed in Table 3.  
Table 3. Summary of engineered proteins studied by chapter 
n/a
n/a
6x-His
6x-His
6x-His
6x-His
GST
GST
GST
n/a
6x-His
6x-His
GST
GST
GST
Fusion 
Tag
pET20b
pET20b
pRSETa
pRSETa
pRSETa
pRSETa
pGEX-2T
pGEX-2T
pGEX-2T
pET20b
pET28a
pET28a
pGEX-2T
pGEX-2T
pGEX-2T
Vector
Design
Design
n/a
Subdomain
Subdomain
Subdomain
Grafting
Grafting
Grafting
n/a
n/a
Grafting
Grafting
Grafting
Grafting
Approach
Tuner(DE3)pLacI
Tuner(DE3)pLacI
Rosetta-gami(DE3)pLysS
OrigamiB(DE3)pLysS
Rosetta(DE3)pLysS
Rosetta(DE3)pLysS
Tuner(DE3)pLacI
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
Cell                        
Strain
AC
AC
Refolding and AC
Subdomain 1
Subdomain 2
Subdomain 3
Chapter Engineered 
Protein
Purification 
Technique
3 CD2.STIM1
CD2.STIM1.Mut1
CD2.Rub.Ca
AC and IEC
AC and IEC
n/a
EGFP.WT
EGFP.EF.172
AC
AC
4 CaM.WT HIC
5 CD2.CaSR.Site3
CD2.CaSR.Site5
CD2.CaSR.Mutants
AC and IEC
AC and IEC
AC and IEC
ECD AC
6 CD2.7E15
CD2.7E15.52I
Refolding and IEC
Refolding and IEC  
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2. MATERIAL AND METHODS 
2.1 Cloning and transformation 
Engineered proteins were cloned by standard PCR reactions by Dr. Yun Huang [38] and 
Dr. Yubin Zhou [39] and details can be found in their PhD dissertations. The competent cells 
used for the transformation procedures were BL21(DE3), BL21(DE3)pLysS, Tuner(DE3)pLacI, 
Rosetta-gami(DE3)pLysS, OrigamiB(DE3)pLysS and/or Rosetta(DE3)pLysS. The antibiotics 
used were ampicillin, kanamycin chloramphenacol, and/or tetracycline. To begin, 50 μL of the 
competent cell were added into labeled tubes, followed by 0.5-1.0 μL of DNA. The tubes were 
then placed on ice for 30 minutes, then in 42 oC water bath for exactly 90 seconds to allow the 
DNA transfer into cell. Following this heat shock, samples were returned to the ice bucket for 2 
minutes. Next, 50 μL of Luria-Bertani (LB) media was added to the tubes and they were then 
placed in an incubator for 30 minutes at 37 oC. After 30 minutes, 50 μL of the cell culture were 
added drop wise to a labeled agar plate, and streaked across the agar surface using a sterile 
triangle. One additional plate was streaked (without DNA) as a control and both were placed at 
37 oC overnight with the agar side of the plate facing up. 
2.2 Protein expression 
2.2.1 Luria-Bertani (LB) media 
For overnight inoculation, a single and healthy clone was removed from a previously 
transformed agar plate using an inoculation loop. The loop was inserted and stirred to release the 
clone into a 1 L flask containing 500 mL LB media (10 g/L peptone from casein, 5 g/L yeast 
extract, and 10 g/L NaCl) and 100 mg/L ampicillin or 30 mg/L kanamycin. The flask was then 
placed in the shaker to incubate overnight at 37 oC at a speed of 220-230 rpm.  
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For the expression of engineered proteins, 50 mL of observable cell growth grown 
overnight was placed into a 4 L flask containing 1 L LB media. Next, either 1000 μL of 
ampicillin (100 mg/L) or 600 μL of 50 mg/mL kanamycin were added for a final concentration 
of 0.03 mg/mL and the flask was placed in the shaker at 37 oC. The optical density (OD) was 
checked at regular intervals to evaluate cell growth using a Shimadzu UV-1601 PharmaSpec 
UV-Vis spectrophotometer with UV Probe software (Shimadzu North America, Columbia, MD). 
When the OD reached approximately 0.6-0.8, cells were induced with 100-500 μL isopropyl ß–
D-1-thiogalactopyranoside (IPTG) which is an effective inducer in the concentration range of 
0.1-1.5 mM. Cells were collected the same day they were expressed at 37 oC or if they were 
expressed at lower temperatures (25 oC or 30 oC) cells were allowed to grow overnight with 
agitation and collected the following day. Cells were collected using high speed centrifugation 
(7,000 rpm) for 20 minutes and stored at -20 oC (Figure 8). 
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Figure 8. Diagram illustrating protein expression in E. coli. 
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2.2.2 Labeled 15N minimal media 
Labeled 15N minimal media was prepared using the following chemicals: K2HPO4·3H2O 
(10.4 g/L), KH2PO4 (4.4 g/L) MgSO47H2O (0.05 g/L), (NH4)Fe(SO4)2·6H2O (0.007 g/L), 20% 
glucose, and 20% 15NH4Cl. The expression procedure using minimal media is similar to that 
explained earlier for LB media (Figure 8). The only difference is the procedure used in the 
inoculation step. It was necessary to inoculate 10 mL of LB media, 10 μL ampicillin, and a 
healthy individual clone from an agar plate that contained 3% glucose in three to four different 
50 ml plastic tubes for at least 8 hours. The best growing cultures were then transferred to a 1 L 
minimal media flask until the OD reached a 0.6 value. Cells were then induced with 150 μl IPTG 
and temperature was reduced to 25 oC overnight. The expressed and further purified proteins 
included 15N labeled atoms that were used in NMR studies. 
2.3 Protein purification 
Engineered proteins were originated using a grafting, a subdomain, or a design approach. 
Some of these proteins had fusion tags which helped for a successful expression and purification 
and other proteins were expressed and purified as wild type proteins for use as controls in future 
experiments. 
 All of the engineered proteins that were grafted into CD2.D1 contained a GST-tag 
(pGEX-2T) and they were purified using affinity and ion exchange chromatography, whereas, 
those proteins that were grafted into EGFP contained a 6x-his-tag (pET28a) and were purified 
using nickel-sepharose affinity chromatography. Proteins generated from the subdomain 
approach also contained a 6x-his-tag (pRSETa). Subdomain 1 and 2 were therefore purified 
using nickel-sepharose affinity chromatography. However, an additional refolding technique was 
utilized to purify subdomain 3. Proteins that were generated using a design approach were tag-
23 
less proteins (pET20b) and they were therefore purified using a refolding technique followed by 
ion exchange chromatography. CaM was another tag-less (pET20b) protein that was purified 
using hydrophobic interaction chromatography. Refer to Table 3 in Chapter 1 for a complete 
table that summarizes all the engineered proteins, fusion tags, vectors, and purification 
technique(s) used.  
2.3.1 Affinity and ion exchange chromatography (GST-tag) 
A 2 L expression cell pellet was re-suspended in 35-50 mL lysis buffer (1% sacosine and 
1 mM EDTA in PBS, pH 7.4) and 1 M DTT was added to the solution to a final concentration of 
5 mM. The resulting solution was subjected to sonication (Branson 450 Sonifier) 7-8 times for 
30 seconds with 1-2 minute intervals between sonications in order to avoid protein degradation 
due to heat produced by the sonicator’s sound waves.  
The solution was then centrifuged at 17,000 rpm for 40 minutes (S34 rotor). The 
supernatant was subsequently filtered with a 0.45 μm filter (Whatman, Florham Park, NJ) and 
the filtered supernatant was then poured in glutathione (GST) agarose beads (GE healthcare) 
affinity columns in order to start protein binding. The flow through was repetitively passed over 
the column 3-5 times for further binding. The affinity columns were washed with 50 mL 1X PBS 
buffer. A 2:5 BioRad protein assay is used to determine if the protein was bound to the GST 
beads.  If the binding was successful a color change was observed on a micro-plate reader from a 
copper to a blue color.  The protein was cleaved adding 20-40 μL per column of thrombin.  The 
cleavage was done overnight at 4 oC with agitation and for an additional 2-3 hours at room 
temperature the following day.  The columns were then washed with 20-50 mL 1X PBS buffer 
per column and allowed to elute the protein.  The BioRad protein assay was used to determine if 
all the protein was eluted (Figure 9). 
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Figure 9. Diagram illustrating protein purification by GST-tag affinity column and ion exchange 
chromatography.  
Proteins were further purified using ion exchange chromatography. The eluted protein’s 
pH was lowered to a 3.0-4.0 range using acetic acid and it was subsequently filtered using 0.45 
μm filter. Filtered solution was injected into SP column using a fast liquid chromatography 
(FPLC) system. Proteins are bound to the column in buffer A (50 mM sodium acetate-acetic acid 
buffer solution, pH 4.5) and they were eluted with buffer B (50 mM Tris-HCl, pH 8.0). The 
FPLC system displayed a chromatogram with a sharp peak when the protein was eluted allowing 
us to collect the relative fractions (Figure 9). Collected fractions were concentrated to 10 ml 
using an Amicon brand concentrating apparatus with a 3-10 kDa molecular weight cutoff 
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membrane. Concentrated solution was extensively dialyzed in 10 mM Tris-HCl buffer pH 7.4 to 
perform further studies. 
2.3.2 Nickel-sepharose affinity chromatography (6x-his-tag) 
A 2 L expression cell pellet was re-suspended in 20 mL extraction buffer (20 mM Tris, 
100 mM NaCl, 0.1% Triton X-100) or 30-50 mL lysis buffer (1% sacosine and 1 mM EDTA in 
PBS, pH 7.4). Cell membranes were broken using sonication or French press. The resulting 
solution was centrifuged for 40 minutes at 17,000 rpm and the extracted supernatant was filtered 
with 0.45 μm pore size filter into a plastic tube. In order to improve protein purity, 1 M 
imidazole was optionally added to the solution so that the final concentration was 20-50 mM.  
Purification of His-tag proteins was completed using a Hitrap 20 mL or 5 mL sepharose 
column and an ÄKTA prime FPLC instrument (Amersham Biosciences, Piscataway, NJ). Buffer 
A (referred to as binding buffer) was comprised of 1 M K2HPO4, 1 M KH2PO4, 250 mM NaCl, 
pH 7.4. Buffer B (referred to as elution buffer) was comprised of buffer A and 0.5 M imidazole. 
The column was first rinsed with a 100 mM EDTA and 1 M NaCl solution in order to remove 
any metals and undesirable impurities. It was then rinsed with ddH2O twice. Following the 
cleaning step, the column was washed with 0.1 M NiSO4 in order to bind Ni2+ onto the column, 
and it was then rinsed again with ddH2O in order to remove any unbound NiSO4. Filtered protein 
was then injected into the column and further eluted out in 8 mL fractions. Collected fractions 
were further purified by dialysis in 2 L of 10 mM Tris-HCl buffer pH 7.4 and using a dialysis 
bag with a molecular weight cutoff of 3500 Da. The dialysis solution was changed every 3 hours 
in order to remove imidazole (Figure 10).  
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Figure 10. Diagram illustrating protein purification by 6x-his-tag affinity column step by step.  
2.3.3 Hydrophobic interaction chromatography 
A 2 L expression cell pellet was re-suspended in 30 mL homogenization buffer (2 mM 
EGTA, 1 mM DTT, 1 mM PMSF in 50 mM Tris-HCl, pH 7.5) and cell membranes were broken 
using French press. The resulting solution was subsequently heated at 80-85 oC in a water bath 
for about 5 minutes and this solution was centrifuged for 40 minutes at 17,000 rpm. The 
extracted supernatant was filtered with 0.45 μm pore size filter into a plastic tube and 1 M CaCl2 
was added to a final concentration of 5 mM. The supernatant was then loaded onto a 
phenylsepharose column that was previously equilibrated with wash 1 buffer (0.5 CaCl2 in 50 
mM Tris-HCl, pH 7.5). The binding process was initially done at room temperature with a 1 
mL/min binding flow and the sample was recycled overnight at 4 oC to ensure complete protein 
binding to the column.  
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Next day, the column was washed with 150 mL wash 1 followed by 150 mL wash 2 
buffer (0.5 mM CaCl2, 500 mM NaCl in 50 mM Tris-HCl, pH7.5). Protein was eluted using 
elution buffer (5 mM Na2EGTA in 50 mM Tris-HCl, pH 7.5) and the different fractions were 
checked using UV-visible spectrophotometry. Relative fractions were collected, concentrated, 
and dialyzed in 20 mM Tris-HCl buffer, pH 7.4 at 4 oC where the dialyzed buffer was exchanged 
every 2-3 hrs (Figure 11). The final protein concentration was calculated using UV-visible 
spectrophotometry, the protein’s extinction coefficient, and the measured absorption at 277 nm.   
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Figure 11. Diagram illustrating protein purification by hydrophobic interaction chromatography 
step by step (phenylsepharose column).  
2.3.4 Urea refolding 
A 1 L expression cell pellet was re-suspended in 30-35 mL PBS buffer, 60 μL benzonase 
nuclease, and 200 μL protease inhibitor. The resulting solution was subjected to French press 
three times. The solution was centrifuged for 30 minutes at 17,000 rpm. The supernatant was 
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discarded and the pellet was re-suspended in 20 mL 2% Titron X-100 in PBS solution and then 
centrifuged for 20 minutes at 17,000 rpm. This procedure was repeated 3-4 times. The washed 
pellet containing the protein was then transferred to two 50 mL plastic tubes and 25 mL of an 8 
M urea (pH 7.3) and 5 mM EDTA (pH 11.3) solution was added to each tube and left at 4 oC 
overnight on a magnetic stirring plate. Next day, the solution was centrifuged for 20 minutes at 
17,000 rpm. The supernatant was collected which contained the solubilized protein that was 
completely unfolded by the 8 M urea solution. It was then necessary to gradually reduce the urea 
concentration in order to refold the protein. The 8 M urea sample was then diluted to 4 M urea 
by adding 25 mL PBS buffer drop wise and by constantly stirring the sample at 4 oC for 2 hours. 
The 4 M urea solution was then transferred to two dialysis bags in order to dialyze them in 2 M 
urea for 4 hours. Dialysis bags were then transferred to a 2 L dialysis buffer (10 mM Tris-HCl 
buffer pH 7.4 and 200 μL protease inhibitor) overnight. The dialysis buffer was subsequently 
changed three times at three hour intervals in order to completely remove urea from solution. 
The dialyzed solution was further purified using ion exchange chromatography. Figure 12 
illustrates a simplified diagram describing the refolding method process.  
Dissolve pellet 
in PBS Buffer
i l ll
i
French press 
(3X)
Centrifuge 
(30 min)
i
i
Wash pellet with 
Titron X-100 (3X)
ll i
i
Dissolve pellet in  
8 M urea (O/N)
i l ll iSlowly dilute to 
4 M urea using 
PBS (4 hrs)
il
i
Dialysis in 2 M 
urea (4 hrs)
i l i i Dialysis using 
desired buffer
i l i i
i
Inject to columnj l
Pure Protein
 
Figure 12. Diagram illustrating protein purification using 8 M urea refolding method.  
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2.4 SDS-PAGE electrophoresis 
Samples to be analyzed were mixed with SDS-PAGE sample buffer (glycerol, 1 M Tris-
HCl buffer pH 6.8, SDS, bromophenol blue, and dH2O) and 5% β-mercaptoethanol to avoid S-S 
bridges formation. Mixed and denatured samples were heated in a boiling water-bath for 10 min. 
They were then loaded into a SDS casting gel containing a stacking gel on top (4% 
polyacrylamide) and a resolving gel on bottom (15% or 8% polyacrylamide). A constant current 
of ~ 110-120 V was applied and the samples were allowed to run until they migrated to the 
bottom of the resolving gel. The gel was stained using Coomassie brilliant blue staining buffer 
and 0.1% Coomassie blue R-250 methanol, acetic acid, dH2O 40:10:50 for 20 min and then 
destained using destaining buffer solution (25% methanol, 7% acetic acid, and dH2O).  
2.5 Protein concentration calculation 
Protein concentration was determined using UV-visible spectrophotometry, the UV 
absorbance at 280 nm or 277 nm (phenylalanine absorbance), the protein’s molar extinction 
coefficient, and the Beer-Lambert Law,  
A = ε b c 
where A is the measured absorbance at 280 nm or 277 nm, ε is the molar extinction coefficient, b 
is the path length (1 cm), and c is the protein’s concentration. The absorbance at 280 nm 
corresponds to tryptophan residues present in CD2 and its variants, while 277 nm corresponds to 
tyrosine residues present in CaM. 
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3. THE GRAFTING APPROACH: PROTEIN PURIFICATION BY 
AFFINITY AND ION EXCHANGE CHROMATOGRAPHY 
3.1 Introduction 
Most Ca2+-binding proteins contain multiple binding sites and they are therefore able to 
bind Ca2+ cooperatively. The grafting approach is an excellent way to examine site-specific 
Ca2+-binding properties. In this approach, a single EF-hand Ca2+-binding loop or predicted Ca2+-
binding sites are inserted into a scaffold protein [12, 15]. Chosen scaffold or host proteins must 
adhere to a series of conformational and stability characteristics, and loop insertions into these 
host proteins must follow certain criteria that are essential for successful and accurate metal-
binding and conformational studies. Domain 1 of CD2 (CD2.D1) and enhanced green 
fluorescence protein (EGFP) were the two chosen host proteins. Therefore, the usage of these 
proteins in combination with a grafting approach will allow us to create an environment to 
evaluate the intrinsic Ca2+-binding affinities of isolated binding sites and it will also allow us to 
develop Ca2+ sensors by exploiting the intrinsic fluorescence properties of EGFP variants. In this 
chapter discussion will focus on the expression and purification of engineered Ca2+-binding 
proteins in which Ca2+-binding loops were inserted into CD2 and EGFP. 
3.1.1 CD2.D1 as a host protein 
CD2.D1 was chosen as a scaffold protein in order to create a model system and in that way 
study Ca2+-binding by protein grafting. CD2 enhances T cell and NK cell activation by 
interacting with CD48 or CD58 on the antigen-presenting cells and is one of the most 
extensively studied non-Ca2+-binding cell adhesion proteins [18]. This protein has high structural 
conformation stability and it is able to maintain its native structure when electrostatic changes 
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have been made to its structure [12]. Therefore, CD2 was converted into a specific receptor for 
Ca2+ by inserting Ca2+-binding loops into this host stable protein (Figure 13).  
 
Figure 13. Model structure of CD2.D1 grafted with a putative Ca2+-binding EF loop. 
STIM1 is a 685 amino acid long transmembrane protein that is located on plasma and 
endoplasmic reticulum (ER) membranes [40]. The ER is essential in store-operated Ca2+ entry 
and actually STIM1 can be considered as a Ca2+ sensor in the ER. The N-terminal region of 
STIM1 facing the ER lumen contains a sterile α–motif (SAM) domain and an EF-hand motif [40, 
41]. This EF-hand motif was inserted into CD2.D1 using the grafting approach in order to study 
its metal-binding activity and dimerization. Also, a STIM1 mutant (STIM1.Mut) was designed 
where two asparagines (D) in position 1 and 3 were mutated to alanines (A) in order to disrupt its 
Ca2+-binding on the EF-loop. The model structure of CD2.STIM1 and CD2.STIM.mut with their 
inserted sequences can be observed in Figure 14. 
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STIM1          A V R N I H K L M D D D A N G D V D V E E S D E F L R E D
STIM1.MUT  A V R N I H K L M A D A A N G D V D V E E S D E F L R E D
 
Figure 14. Model structure of CD2.STIM1 and CD2.STIM1.Mut. EF-hand motifs were inserted 
at position 52 connected by three Gly residues at both ends of the sequence. 
The rubella virus is a member of the family Togaviridae (genus Rubivirus) and it causes a 
disease commonly known as rubella [42-44].  This single-stranded enveloped virus has a genome 
size of 9,762 nucleotides [42-44]. This genome consist of two long open reading frames (ORFs): 
a 5’-proximal ORF encoding nonstructural proteins (NSP) and a 3’-proximal ORF encoding 
structural proteins, one capsid protein, and two envelope glycoproteins [44, 45]. A Ca2+- binding 
motif (12 residues long) located within the NS protease domain of the 5-proximal ORF of RUB 
was predicted and grafted between Gly53 and Ala54 by PCR into CD2 [44]. The prediction was 
done based on analysis of current data related to EF-hand proteins (Figure 15).  
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Figure 15. Sequence alignment of EF-hand Ca2+-binding motif RUBCa (RV) and other EF-hand 
motifs [44]. 
3.1.2 EGFP as a host protein 
Green fluorescence protein (GFP) was first discovered and isolated by Shimomura and his 
group in 1962 from a jellyfish, Aequorea victoria [46]. Since then, a series of GPF variants has 
been created in order to enhance its biochemical characteristics. For example, enhanced GFP 
(EGFP) is a GFP variant in which point mutations (F64L and S65T) were done in order to 
enhance this protein’s folding efficiency [46, 47]. EGFP has been used as a host protein to 
develop sensors by grafting Ca2+-binding motifs into sensitive locations of this protein by 
choosing three different locations that were solvent accessible [48]. One of these sensors was 
EGFP-172-EF-III in which the Ca2+-binding motif of CaM, loop III (DKDGNYISAAE) and the 
EF-hand motif (EEEIREAFRVFDKDGNGYISAAELRHVMTNL) were grafted into EGFP [48]. 
This sensor was named Ca-G1 and its motifs were inserted in position 1 of EGFP that 
corresponded to Glu172-Asp 173 within loop 9 [48] Figure 16. 
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Figure 16. Model structure of a EGFP-based Ca2+ sensor (Ca-G1) located in position 1.  
3.2 Results and discussion 
Engineered proteins were generated using a grafting approach where CD2.D1 and EGFP 
were used as host proteins. The following section is divided into two parts. The first part 
includes the expression and purification of CD2-WT and its variants while the second part 
discusses the expression and purification of EGFP-WT and one of its variant. 
3.2.1 Expression and purification of CD2-WT and variants by GST-fusion affinity and 
ion exchange chromatography 
3.2.1.1 CD2-WT expression 
CD2-WT was expressed in E. coli BL21(DE3) at 37 oC as a fusion engineered protein 
with a GST-tag in a pGEX-2T vector. The exponential expression growth curve for CD2-WT 
clearly shows that the proteins reached an OD at 600 nm of approximately 2.0, 3-4 hrs after 
induction (Figure 17A). The SDS gel confirmed that the protein was successfully expressed 
since no protein was observed BI, but after IPTG induction (AI) protein expression increased 
every hour, based on increased band thickness observed as a function of time (Figure 17B). 
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Figure 17. (A) CD2-WT expression growth curve (Vector: pGEX-2T, LB media, BL21(DE3), 
37 oC expression). (B) CD2-WT expression in E. coli. 
3.2.1.2 CD2-WT purification 
CD2-WT was purified using affinity (GST-tag) and ion exchange chromatography. The 
purification SDS gel shows that most of the protein was in the soluble form (Sup) and that the 
GST-tag located on the protein bound to the column (BAB), even though some protein was still 
left in the waste (Wst) which is due to incomplete binding of the protein with the sepharose 
column. The GST-tag was effectively cleaved using thrombin (BAC), and protein was eluted out 
(Elu) using 1X PBS buffer (Figure 18A). The pH of the eluted protein was then reduced to ~ 3.0 
using acetic acid for subsequent injection into an ÄKTA FPLC system containing an ion-
exchange column. The chromatogram showed that the relevant fractions were 18 to 21 (Figure 
18B) and the SDS gel confirmed that these fraction showed >95% purity (Figure 18A). These 
fractions were collected and subjected to dialysis in 10 mM Tris-HCl buffer, pH 7.4. The final 
concentration was 1.8 mM in ~ 2 mL and the final yield was 23.4 mg/L. 
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Figure 18. CD2-WT purification using affinity (GST-tag) and ion exchange chromatography. 
(A) SDS gels: GST-tag affinity column chromatography (left) eluted fractions after ion exchange 
chromatography (right) (B) ion exchange chromatogram (collected fractions 18-21). 
3.2.1.3 CD2.STIM1 and CD2.STIM1.Mut expression 
CD2.STIM1 and CD2.STIM.Mut were expressed in E. coli BL21(DE3) at 37 oC as a 
fusion engineered protein with a GST-tag in a pGEX-2T vector. The exponential expression 
growth curve for CD2.STIM1 clearly shows that the protein reached an OD at 600 nm of 
approximately 1.4, 4-5 hrs after induction (Figure 19A). The SDS gel confirmed that the protein 
was successfully expressed since no protein was observed BI but after IPTG induction (AI) 
protein expression increased every hour, based on increased band thickness observed as a 
function of time (Figure 19B). CD2.STIM1.Mut was expressed using the same conditions as 
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those used for CD2.STIM1 and a similar expression trend was observed. SDS gel electrophoresis 
confirmed the results.  
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Figure 19. (A) CD2.STIM expression growth curve (Vector: pGEX-2T, LB media, BL21(DE3), 
37 oC expression). (B) CD2.STIM expression in E. coli. 
3.2.1.4 CD2.STIM1 and CD2.STIM1.Mut purification 
These two engineered proteins were purified using affinity (GST-tag) and ion exchange 
chromatography. The purification SDS gel shows that most of the protein was in the soluble 
form (Sup) and that the GST-tag located on the protein bound to the column (BAB), even though 
some protein was still left in the waste (Wst) due to incomplete binding of the protein with the 
sepharose column. The GST-tag was effectively cleaved using thrombin (BAC), and protein was 
eluted out (Elu) using 1X PBS buffer (Figure 20). The pH of the eluted protein was then reduced 
to ~ 3.0 using acetic acid in order to be consequently injected into an ÄKTA FPLC system 
containing an ion-exchange column. The chromatogram showed that the relevant fractions were 
17 to 19. These fractions were collected and subjected to dialysis in 10 mM Tris-HCl buffer, pH 
7.4. The final concentration for CD2.STIM1 was 1.1 mM in ~2 mL and the final yield was 14.4 
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mg/L. A similar purification trend was observed for CD2.STIM1.Mut. Its final concentration 
was 770.9 μM in ~2mL and the yield was 10.0 mg/L. 
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Figure 20. CD2.STIM purification using affinity (GST-tag) and ion exchange chromatography. 
(A) SDS gels: GST-tag affinity column chromatography and eluted fractions after ion exchange 
chromatography (B) ion exchange chromatogram (collected fractions 17-19). 
3.2.1.5 CD2.RUB.Ca expression 
 This protein was also expressed in E. coli BL21(DE3) at 37 oC as a fusion engineered 
protein with a GST-tag in a pGEX-2T vector. The exponential expression growth curve for 
CD2.RUB.Ca clearly shows that the protein reached an OD at 600 nm of approximately 1.8, 3-4 
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hrs after induction (Figure 21A). The SDS gel confirmed that the protein was successfully 
expressed since no protein was observed BI but after IPTG induction (AI) the protein expression 
increased every hour, based on increased band thickness observed as a function of time (Figure 
21B).  
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Figure 21. (A) Rub.Ca.EF expression growth curve (Vector: pGEX-2T, LB media, BL21(DE3), 
37 oC expression). (B) RubCa.EF expression in E. coli. 
3.2.2 Expression and purification of EGFP-WT and a variant using 6x-his-tag affinity 
chromatography 
3.2.2.1 EGFP-WT and EGFP-EF-172 expression and purification 
Green fluorescence proteins are different form CD2 since they contain a chromophore 
located at the center of a beta barrel structure. Chromophore formation is usually achieved at low 
temperatures since these temperatures allow proper chromophore maturation. The chromophore 
is responsible for this protein’s characteristic green color after its expression in E. coli and 
further purification.  
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EGFP-WT and EGFP-EF-172 proteins were expressed in E. coli BL21(DE3) as fusion 
engineered proteins containing a 6x-his-tag in a pET28a vector. Cells were grown in LB media 
containing 30 μg/mL kanamycin at an initial temperature of 37 oC. Temperature was 
subsequently reduced after IPTG induction (OD 0.6) to 30 oC overnight in order to increase 
chromophore maturation. Both of these proteins were successfully expressed (Figure 22A and 
Figure 23A) and were further purified using 6x-his-tag affinity chromatography (Figure 22B and 
Figure 23B). Proteins were soluble after cells were disrupted using sound waves (sonication) and 
the collected fractions were dialyzed in 10 mM Tris-HCl buffer, pH 7.4 in order to remove the 
high imidazole concentration used to elute the protein. Fractions 12 and 13 for EGFP-WT and 13 
and 14 for EGFP-EF-172 showed higher purity in the SDS gels (Figure 22B and Figure 23B) and 
they were used for crystallization procedures. The final yields for the collected fractions were 
73.6 mg/L and 10.2 mg/L for EGFP-WT and EGFP-EF-172 respectively. 
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Figure 22. (A) EGFP-WT expression in E. coli (Vector: PET20a, LB media, BL21(DE3). (B) 
EGFP-WT purification SDS gel using 6x-his-tag affinity chromatography.  
41 
M     F8    F10     F11     F12      F13   F14   F15    F16  F18
O/N 
M        BI         AI
A B kDa
64―
24―
14―
6―
kDa
64―
24―
14―
6―
 
Figure 23. (A) EGFP-EF-III-172 expression in E. coli (Vector: PET20a, LB media, BL21(DE3). 
(B) EGFP-EF-III-172 purification SDS gel using 6x-his-tag affinity chromatography.  
3.2.2.2 EGFP-WT and EGFP-EF-172 crystallization 
Proteins are able to form crystals by aligning themselves in repeating series of “unit cells” 
forming a crystalline lattice, these crystalline lattices might be formed utilizing one of the most 
common crystallization techniques, the hanging-drop method [49]. In this method, a drop 
containing the purified protein, buffer, and precipitant is placed on a glass cover slip and it is 
allowed to equilibrate with larger reservoirs containing similar buffers and precipitants in higher 
concentrations and at different conditions.  
To date, efforts to crystallize EGFP-WT in our laboratory have been unsuccessful. 
Samples were prepared for both EGFP-WT and EGFP-EF-172 at room temperature using the 
following precipitant solution: 10-15% PEG 4000 in 50 mM HEPES pH 8.0-8.5, 50 mM MgCl2, 
10 mM 2-mercaptopethanol. Phase separations and oil shape profiles were observed in the 
samples due either to low monovalent salt concentration or because the precipitant concentration 
was too high (Figure 24). The observed results indicate that salt and PEG concentrations need to 
be further optimized in order to obtain crystals for this protein.  
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Figure 24. EGFP-WT crystallization. Phase separation and oil shape profiles were observed.  
Similar conditions were used to grow crystals for EGFP-EF-172. Different PEG 
concentrations (10-15%) and different pH (8.0-8.5) were also tested. The best conditions that 
showed microcrystals were pH 8.0 and 8.4 and 10% and 13% PEG 4000 concentration (Figure 
25). These conditions are still under investigation because these microcrystals appear to be 
overlapping each other, forming crystal clusters. These clusters can be avoided by reducing 
crystallization temperature in order to slow down the nucleation process. 
pH 8.0          
10% PEG 4000
pH 8.0          
13% PEG 4000
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Figure 25. EGFP-EF-172 crystallization. Microcrystal formation and crystal clusters profiles 
were observed. 
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3.3 Summary 
A grafting approach was used to insert Ca2+-binding motifs into host proteins, CD2.D1 and 
EGFP. These host proteins are easily expressed and purified, tolerate mutations, and their native 
structures are not disrupted by strategic insertions of foreign sequences. Expression and 
purification of these engineered proteins are initial and essential steps to perform future 
physicochemical experiments (e.g. CD2, MS, NMR, titrations etc.). All engineered proteins were 
expressed at 37 oC in E. coli BL21(DE3) LB media conditions using IPTG as a protein inducer. 
CD2-WT, CD2.STIM1, and CD2.STIM1.Mut were purified using affinity (GST-tag) and ion 
exchange chromatography. Conversely, EGFP-WT and EGFP-172-III-172 were purified using 
6x-his-tag affinity chromatography and the collected fractions were used to grow crystals using 
the hanging-drop method. Optimum salt and precipitant concentrations are still under 
investigation since we were unable to obtain EGFP-WT crystals, and crystal clusters were 
obtained for EGFP-EF-172. The purities of our engineered proteins were tested by SDS gel 
electrophoresis and their yields and concentrations were between 10-23 mg/L and 366-1800 μM 
in ~ 2 mL (Table 4). 
Table 4. Concentrations and yields obtained for engineered proteins that were created using a 
grafting approach 
 
65773.6EGFP-WT
77110.0CD2.STIM1.Mut
36610.2EGFP-EF-172
Protein Yield 
(mg/L)
Concentration
(μM) in 2 mL
CD2.WT 23.4 1800
CD2.STIM1 14.4 1100
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4. CALMODULIN: AN INTRACELLULAR PROTEIN PURIFIED BY 
HYDROPHOBIC INTERACTION CHROMATOGRAPHY 
4.1 Introduction 
CaM is a small (~17 kDa) intracellular Ca2+-binding protein with four EF-hand motifs or 
loops. This important and well-studied protein is able to regulate a series of important cellular 
functions including secretion, metabolism, motility, signal transduction, and cell division and 
growth [7]. Its primary structure is highly conserved in all cell types and it has been also 
identified in prokaryotic systems where it changes its conformation upon Ca2+ addition [50].  
CaM has four Ca2+-binding sites located in four different EF-loops since this protein has a 
helix-loop-helix conformation (Figure 26A). These loops have different physiochemical 
properties and amino acid residues that will influence their metal-binding affinities, especially its 
interaction with Ca2+ (shown as dark grey spheres). For example, EF-loop I has two positively 
changed residues at positions 2 and 11 while EF-loop IV contains an additional negatively 
charged residue at position 11 (Figure 26B). Previous researchers in Dr. Yang’s laboratory have 
performed studies in which EF-loops of CaM were inserted into CD2 domain 1 (CD2.D1) in 
order to study their Ca2+-binding properties and affinities [50]. Figure 26C illustrates the model 
structure of one of the grafted loops. CaM EF-loop III was grafted into CD2.D1 at position 52 
connected by five Gly residues (3 at one end and 2 at the other end) in order to increase the 
loop’s flexibility [50]. The insertion of the EF-loops did not change the host protein’s 
conformation and it was concluded that EF-loop IV exhibited the weakest metal-binding affinity 
while EF-loop I exhibited the strongest binding affinity [50].  
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Figure 26. Three-dimensional structures of calmodulin using MOLSCRIPT.67. (A) Ribbon 
diagram of CaM-calcium loaded form. (B) Local structures of loop I (top) containing two 
positively charged residues and loop IV (bottom) containing an additional negatively charged 
residue at loop position 11. (C) Model structure of domain 1 of CD2 (CaM-CD2-III-5G-52) with 
EF-loop III grafted at position 52 (Trp-32 and Tyr-76 are highlighted in yellow) [50]. 
4.2 Results and discussion 
4.2.1 CaM-WT expression using two growth media 
CaM-WT was expressed in E. coli in a pET20b vector and using LB and 15N labeled 
minimal media. The cell strain used was BL21(DE3) and the IPTG concentration used to induce 
protein expression was 150 mM in both media. The temperature for expression was different for 
both media since 15N labeled minimal media provides fewer nutrients for bacterial growth 
compared to those provided by LB media. CaM-WT was successfully expressed at 37 oC in LB 
media and bacteria were collected after 6 h induction (Figure 27). In contrast, this protein was 
expressed at 25 oC in the minimal media and it was left in the shaker with agitation for an 
overnight period (Figure 27). A clear band was therefore observed around the 14 kDa marker 
band because the protein’s molecular weight is ~17 kDa. 
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Figure 27. CaM-WT expression in two different growth media.  
4.2.2 CaM-WT purification 
CaM-WT was purified using hydrophobic chromatography and a phenyl-sepharose column. 
This well studied protein exposes a hydrophobic surface upon Ca2+ binding and this hydrophobic 
region allows for its purification since it can bind to the phenyl-sepharose column and it can be 
eluted out by using chelating agents like EGTA. The purification SDS gels for two proteins 
expressed in different media can be observed in Figure 28A (LB media) and Figure 28B 
(minimal media). The SDS gels clearly show that most of the protein was in the soluble form 
(Sup) after cells were disrupted with high pressure. It is also possible to observe that the protein 
bound completely to the phenyl-sepharose column because no protein was left in the waste (Wst) 
after intensive binding, and that the 8 mL eluted fractions contained high quantity of pure 
protein. Relevant collected fractions were concentrated and dialyzed in 20 mM Tris-HCL buffer, 
pH 7.4 and the dialyzed buffer was exchanged three times with time intervals between 2-3 h and 
sometimes for an overnight period.   
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Figure 28. CaM-WT purification using hydrophobic chromatography. (A) CaM-WT purification 
and eluted fractions when protein was expressed in 1 L LB media. (B) CaM-WT purification and 
eluted fractions when protein was purified in 2 L 15N labeled media. 
Protein concentration was calculated using UV-visible spectroscopy, the extinction 
coefficient (3030 M-1 cm-1), and the protein’s absorbance at 277 nm. A typical UV-visible 
spectrum of CaM-WT can be observed in Figure 29 where it is also possible to observe that the 
UV absorbance at 277 nm for tyrosine and phenylalanine at 257 nm. For the pure protein 
expressed in LB media the A277 nm was 0.2676, whereas for the pure protein expressed in 
minimal media the A277 nm was 0.2074. The obtained absorbances at 277 nm were divided by the 
extinction coefficient and multiplied by a dilution factor of 50. The calculated final 
concentrations and yields of purified proteins were 4.4 mM and 74.8 mg/L (expressed in LB 
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media) and 3.4 mM and 57.8 mg/L (expressed in 15N labeled minimal media) in ~2 mL. It is 
normal to obtain a higher amount of protein when the protein is expressed in LB media since the 
nutrients provided by these media are higher than those provided by minimal media.  
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Figure 29. CaM-WT UV-visible spectrum after protein was expressed in two growth media and 
purified by hydrophobic chromatography. Protein concentrations were calculated using the 
protein’s absorbance at 277 nm, its extinction coefficient, and Beer-Lambert Law.   
4.2.3 Summary 
CaM is an important intracellular Ca2+-binding protein with four EF-hand motifs that 
undergoes a conformation change upon Ca2+ binding. CaM-WT was successfully expressed in E. 
coli BL21(DE3) using two different media and temperatures. Expression in LB media was 
performed at 37 oC whereas expression in 15N minimal media was performed at 37 oC overnight 
because this media provided fewer nutrients to the cells and it required a longer incubation time. 
CaM-WT was subsequently purified using hydrophobic interaction chromatography (phenyl-
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sepharose column) since this protein exposes a hydrophobic region when it binds to Ca2+ 
allowing its purification. The final yield for CaM-WT expressed in LB media was 74.8 mg/L 
which was higher to that obtained when it was expressed in 15N minimal media (57.8 mg/L) due 
to the media nutrients and the expression time and temperature. Future experiments were 
performed with the purified protein. For example, CaM-WT expressed in 15N minimal media 
was used to perform NMR experiments to further study the effect that Ca2+ might have on this 
protein’s molecular structure.  
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5. THE ROLE OF CALCIUM AND THE EXTRACELLULAR 
CALCIUM-SENSING RECEPTOR  
5.1 Introduction  
The CaSR was cloned from bovine parathyroid tissue in 1993 by Dr. Brown and his 
colleagues and since then researchers have been rigorously working in order to study this 
important receptor [51-53]. The receptor is most highly expressed in organs like the parathyroid, 
thyroid, and kidney and it is a key and crucial player in Ca2+ homeostasis maintenance since it 
regulates the secretion of parathyroid hormone (PTH) [11, 52, 54, 55]. For example, primary 
hyperparathyroidism (HPTH) involves an over activity of the parathyroid glands causing PTH 
overproduction and elevated blood Ca2+ levels or a hypercalcemia condition [56]. 
Overproduction of  PTH can lead to osteoporosis, kidney stones, peptic ulcers, and high blood 
pressure [55]. Several diseases have been associated with mutations in the CaSR that are 
intrinsically linked with Ca2+ homeostasis disorders. For instance, familial hypocalciuric 
hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT) were associated with 
inactivating mutations affecting one or both alleles [52].  
The CaSR belongs to family C of G protein-coupled receptors and it recognizes Ca2+ as its 
physiological ligand. It is comprised of a huge extracellular domain (ECD) of approximately 600 
amino acid residues, a seven transmembrane domain (7 TMD), and an intracellular domain of 
approximately 200 amino acids [11, 55, 57]. The CaSR is a dimer and its ECD is connected to 
the 7 TMD by a cysteine-rich region. The crystal structure for this receptor has not yet been 
elucidated yet but a model structure based on the X-ray structure of mGLuR1 has been 
developed in order to illustrate the three important domains that comprise the CaSR (Figure 30). 
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This model structure illustrates the dimeric form of the CaSR and it also shows the location of 
the five predicted Ca2+-binding sites.  
 
Figure 30. Molecular modeling of the dimeric extra cellular domain (ECD) of the Ca2+-sensing 
receptor (CaSR) based on the ECD X-ray structure of mGluR1 [58].  
5.2 Two approaches to study the metal-binding properties of the CaSR 
5.2.1 Grafting approach 
Five putative Ca2+-binding sites were predicted and two of them (site 3 and 5) were 
grafted into CD2.D1 using a well-studied grafting approach developed in Dr. Yang’s lab. 
Therefore, we have converted CD2 into a specific receptor for Ca2+ by inserting a Ca2+-binding 
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site into CD2.D1 between glycine 53 (G53) and serine 52 (S52) (Figure 31). The location of the 
Ca2+-binding sites on the ECD (Figure 32A) and the proposed model structures for all five sites 
is illustrated in (Figure 32B) where sites 3 and 5 are circled in red. Lobe 1 of the ECD of the 
CaSR contains sites 4 and 5, whereas lobe 2 contains sites 1, 2, and 3. Site 1 is expected to be 
important in Ca2+-induced conformational changes since this site is located at a hinge region 
connecting both lobes. Additionally, the physiochemical properties of CD2.CaSR site 3 and 5 
and their mutants are summarized in Table 5 where it is possible to observe the individual 
grafted sequences, isoelectric points (pI), and molecular weights (kDa) for sites 3 and 5 and their 
mutants. Glycine linkers were added at each insertion site in order to study the loop’s flexibility 
upon linker addition.  
Table 5. Grafted sequences, isoelectic points (pI), and molecular weights for CD2.CaSR site 3, 
site 5, and mutants 
 
 
12.97.19G I E K F R E E A A A R D I GCD2.CaSR3.Mut3
12.97.19G I A K F R E E A E E R D I GCD2.CaSR3.Mut1
14.07.38G H A A S G D R F S N S S T A F R P L C T G D E N ICD2.CaSR5.Mut1
13.35.59K S G I E K F R E E A E E R D I G ACD2.CaSR3 linker
12.97.19G I E K F R A A A E E R D I GCD2.CaSR3.Mut2
13.05.59G I E K F R E E A E E R D I GCD2.CaSR3
12.97.38K S G G G H E E S G D R F S N S S T A F R P L C T G D E N I G G G S ACD2.CasR5 linker
14.15.97G H E E S G D R F S N S S T A F R P L C T G D E N ICD2.CaSR5
14.07.38G H E E S G D R F S N S S T A F R P L C T G A A N ICD2.CaSR5.Mut2
Protein Grafted Sequence pI MW (kDa)
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Figure 31. Model structure of CD2.D1 grafted with a putative Ca2+-binding site inserted 
between serine 52 and glycine 53. 
Site 1 Site 2 Site 3 Site 4 Site 5
A
B
 
Figure 32. (A) ECD of the CaSR illustrating possible locations of five potential Ca2+-binding 
sites in lobes 1 and 2 and the predicted residues at each site. (B) Proposed structures for potential 
Ca2+-binding sites in the ECD of the CaSR. Site 3 and site 5 shown in red.  
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5.2.2 Subdomain approach 
The strategy of the subdomain approach is to chop intact CaSR into three subdomains 
containing the identified Ca2+-binding sites. The objective of this strategy is to understand the 
cooperativity of coupled Ca2+-binding sites and to study Ca2+-induced conformational changes 
[10]. Three constructs were designed encompassing subdomains that include different numbers 
of predicted Ca2+-binding sites of the CaSR. Subdomain 1 contains CaSR sites 1, 2 and 3, 
subdomain 2 contains sites 2 and 3 in lobe 2, and subdomain 3 contains sites 4 and 5 in lobe 1 
(Figure 33).  
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Figure 33. Diagram illustrating the subdomain approach: ECD of the CaSR is chopped into 3 
subdomains. Subdomain 1 contains sites 1, 2, and 3. Subdomain contains sites 2 and 3.  
subdomain 3 contains sites 4 and 5.  
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The physiochemical properties of the three subdomains including the extinction 
coefficient, the isoelectric point, the number of cysteine residues, and the molecular weight 
(kDa) can be observed in Table 6. 
Table 6. Physiochemical properties of three subdomains located in the ECD of the CaSR 
Protein Amino acid from
CaSR
Extinction 
Coefficient (M-1 cm-1)
Cys No. pI MW 
(kDa)
Subdomain 1 S132-A300 36,130 1 4.59 22.9
Subdomain 2 R185-A324 34,850 1 4.62 20.3
Subdomain 3 A323-G494 27,550 5 5.05 23.8
 
5.3 Results and discussion 
5.3.1 CD2.CaSR site 3 and 5 expression and purification using GST-fusion technology 
5.3.1.1 CD2.CaSR site 3 and 5 expression in LB media 
Site 3 and site 5 from the CaSR were inserted into CD2.D1 and they were successfully 
expressed as fusion proteins with a GST-tag in a pGEX-2T vector transformed into E. coli cell 
strain BL21(DE3) and IPTG was used as the inducer. The exponential expression growth curve 
clearly shows that the proteins reached an OD at 600 nm of approximately 2.0 300-350 min (3-4 
hrs) after induction (Figure 34A). SDS gels confirmed that the proteins were successfully 
expressed since protein expression was not observed before induction (BI) but after IPTG 
induction (AI) protein’s expression increased every hour as the bands were getting thicker and 
thicker as the hours were elapsing (Figure 34B). 
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Figure 34. (A) CD2.CaSR site 3 and site 5 expression growth curve (Vector: pGEX-2T, LB 
media, cell strain: BL21(DE3), 37 oC expression). (B) SDS gels showing CD2.CaSR site 3 (left) 
and site 5 (right) expression. 
 These two proteins were purified using affinity (GST-tag) and ion-exchange 
chromatography. Engineered proteins are frequently subject to solubility problems but in this 
case the amount of soluble protein (in the Sup form) that was obtained after cell disruption was 
enough to perform future purification steps. The supernatant was poured into sepharose-columns 
where the GST was initially bound to the column (BAB), subsequently cleaved using thrombin 
(BAC), and eluted out (Elu) using 1X PBS buffer (Figure 35). The pH of the eluted protein was 
then reduced to ~3.0 using acetic acid for subsequent injection into an FPLC system containing 
an ion-exchange column. The chromatogram revealed relevant fractions that were collected and 
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subjected to dialysis in 10 mM Tris buffer pH 7.4. Both proteins showed a clear and pure band 
around ~14 kDa (site 5) and ~13 kDa (site 3) on the SDS gels Figure 35A and Figure 35B 
respectively.  
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Figure 35. CaSR site 3 and site 5 purification using affinity (GST-tag) and ion exchange 
chromatography. SDS gels and ion exchange chromatograms for (A) CaSR site 5 and (B) CaSR 
site 3.  
5.3.1.2 CD2.CaSR site 3 and 5 expression in minimal media 
Additionally, efforts were made to express and purify CD2.CaSR site 3 and 5 in 15N 
labeled minimal media for NMR analysis to obtain structural information of the predicted sites. 
Both proteins were successfully expressed and purified using similar approaches as those 
employed for regular LB expression. The expression level was reduced to that observed in LB 
media expression because minimal media provided fewer nutrients for bacterial growth (Figure 
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36A). Since the expression level was reduced, the final eluted protein amount was also reduced 
when it was purified by affinity and ion exchange chromatography as confirmed by the SDS gels 
of both proteins (Figure 36B).  
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Figure 36. (A) Expression of CaSR site 3 and site 5 in 15N labeled minimal media (BL21(DE3), 
37 oC expression). (B) Purification of CaSR site 3 (left) and site 5 (right) by GST-tag affinity 
column.  
5.3.2 Subdomain 1 expression and purification optimization 
5.3.2.1 Expression and cell disruption using different vectors  
Subdomain 1 expression was performed using fusion technology in order to compare the 
protein’s expression and solubility after cell disruption. Three different vectors were evaluated: 
pGEX-2T (GST-tag), pET32a (6x-his and thx-tag), and pRSETa (6x-his tag). The expression 
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conditions were the same (E. coli BL21(DE3) at 37 oC) for all three vectors. Subdomain 1 
showed a higher expression level when it was expressed using pGEX-2T and pET32a, but it was 
also expressed to a lower extent in pRSETa (Figure 37A). Protein solubility was investigated by 
breaking the cell using sonication. The protein formed inclusion bodies in the C/P in all three 
cases as observed in Figure 37B. Most of the protein was therefore identified within the C/P and 
not in the Sup form. The only vector that showed a significant amount of protein in the soluble 
form was pET32a but the thx-tag could not be removed from the target protein.      
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Figure 37. Subdomain 1 expression and cell disruption using three vectors. (A) Protein was 
expressed at 37 oC in E. coli BL21(DE3) using pGEX-2T (GST-tag), pET32a (6x-his-thx-tag), 
and pRSETa (6x-his-tag). (B) Cell disruption in order to investigate subdomain 1 solubility. 
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5.3.2.2 Subdomain 1 expression optimization using pRSETa 
Subdomain 1 was cloned in pRSETa vector between BamHI and EcoRI restriction sites 
by Dr. Yun Huang. This vector contained a 6x-his-tag region that was used for further 
purification. The 6x-his-tag not only facilitated the subdomain 1 purification, but the protein’s 
expression was further optimized by utilizing different cell strains and temperatures.  
Protein was transformed and expressed in four E. coli cell strains: BL21(DE3), 
BL21(DE3)pLysS, tuner(DE3)pLacI, and rosetta(DE3)pLysS. These cells strains have different 
properties and these properties had diverse effects in subdomain 1 expression and further 
purification. All the chosen cell strains were T7-based expression systems that control proteases 
at the cellular level. The pLysS plasmid provided a reduction of basal expression and therefore a 
tight expression was expected. Rosetta cell strain offered a universal translation because it 
provided tRNAs that rarely occur in E. coli. Additionally, both rosetta and tuner had deletions in 
the lacY gene (lac permease) that allowed these cell strains to control expression levels upon 
different IPTG concentrations.  
Cells were induced when the OD reached ~0.6 with IPTG. The expression growth curves 
show that the maximum OD or the maximum amount of bacteria that grew in the media fell 
between 1.0-1.2 when the protein was expressed at 37 oC (Figure 38A), and that the OD was 
higher between 1.2-1.8 when the protein was expressed at 30 oC overnight (Figure 38B). A 
higher OD reading was observed for BL21(DE3) at both temperatures and rosetta(DE3)pLysS 
showed the lowest OD reading at 30 oC. These graphs illustrate typical exponential bacterial cell 
growth curves where bacteria exhibit a slow initial growth rate (~0 to 200 min) which increases 
to a faster exponential growth rate (~200 to 400 min) until it reaches a stationary phase (~400 to 
1000 min).   
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Figure 38. Subdomain 1 expression growth curve using four cell strains and two temperatures. 
(A) Protein expressed at 37 oC (B) Protein expressed at 30 oC overnight.  
 Additionally, the SDS gel shows that subdomain 1 was successfully expressed in all cell 
strains at 37 oC and that the expression band was thicker when this protein was expressed using 
rosetta(DE3)pLysS (Figure 39A).  Additionally, this protein was not expressed when 
BL21(DE3) was used as the cell strain at 30 oC overnight even though its OD was the highest 
among the other three cell strains (Figure 38B and Figure 39B) . This means that having a high 
OD does not guarantee that the protein is being expressed correctly. In contrast, subdomain 1 
was successfully expressed in the other three cell strains at 30 oC expression. The best cell 
strains that expressed subdomain 1 were rosetta(DE)pLysS and tuner(DE3)pLacI at 30 oC 
overnight (Figure 39B). The intensity change was calculated using ImageJ software (National 
Institutes of Health, Bethesda, MD). The cell strain that showed the higher intensity change BI 
and AI was rosetta(DE3)pLysS at both temperatures and the intensity change was more evident 
when cells were expressed at low temperatures (Figure 39C). This means that lowering the 
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temperature increased protein expression since proteins had more time to properly fold and the 
bacteria was able to grow longer since expression at lower temperatures is usually  performed 
overnight.  
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Figure 39. Subdomain 1 expression optimization using four cell strains and two temperatures. 
(A) Protein was expressed at 37 oC (B) Protein expressed at 30 oC overnight. (C) Intensity 
change AI/BI for subdomain 1 expression using different cell strains and temperatures. 
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5.3.2.3 Subdomain 1 purification using affinity chromatography  
Expressed proteins were further purified using affinity chromatography and a Ni2+-
sepharose column using the 6x-his rich region provided by the pRSETa vector. Cells were 
disrupted using French press and it was found that a larger proportion of insoluble aggregates 
was formed when the protein was expressed at 37 oC. The cell strain that formed the highest 
amount of insoluble aggregates present in the C/P was BL21(DE3) and as a consequence this 
strain presented the lowest yield (1.2 mg/L) and concentration (26 μM) among all other cell 
strains (Table 7 and (Figure 40A). In comparison, BL21(DE3)pLysS and rosetta(DE3)pLysS 
exhibited better yields (4.0 mg/L and 6.2 mg/L) and concentrations (88 μM and 135 μM 
respectively) and, although the protein still formed inclusion bodies, a significant amount of 
protein was soluble and could be further injected into the FPLC system and eluted out with high 
(50 mM) imidazole concentration (Table 7, Figure 40B, and Figure 40C). Relevant eluted 
fractions from the FPLC system were collected, concentrated down, and dialyzed in 10 mM Tris-
HCl buffer, pH 7.4 in order to remove imidazole from the protein.  
Table 7. Subdomain 1 concentrations and yields after 6x-his-tag affinity chromatography 
Cell strain Concentration (μM)*
(37 oC)
Yield (mg/L)
(37 oC)
Concentration (μM)*
(30 oC)
Yield (mg/L)
(30 oC)
BL21(DE3) 26 1.2 n/a n/a
BL21(DE3)pLysS 88 4.0 306 14.0
Tuner(DE3)pLacI n/a n/a 503 23.0
Rosetta(DE3)pLysS 135 6.2 788 36.1
* Protein volume ~ 2 mL  
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Figure 40. Subdomain 1 purification using 6x-his-tag affinity chromatography. Protein was 
expressed in LB media at 37 oC using three different cell strains: (A) BL21(DE3) (B) 
BL21(DE3)pLysS and (C) Rosetta(DE3)pLysS.  Red boxes: most of the protein formed 
inclusion bodies or insoluble aggregates in the cell pellet and a low amount of soluble protein 
was present in the supernatant.  
Subdomain 1 was more soluble when it was expressed at 30 oC and these results can be 
corroborated by the purification SDS gels when they were expressed in three different cell 
strains (Figure 41). Inclusion bodies were still present in C/P but to a lesser extent compared to 
expressed protein at 37 oC. We were able to obtain higher yields and concentrations when the 
protein was expressed at a lower temperature (Table 7 and Figure 42). Lower temperature 
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expression improved the protein’s solubility because bacteria grew at a slower rate and the 
protein had more time to fold properly (Figure 41A-C). The cell strain that had the highest yield 
and concentration (in ~2mL) was rosetta(DE3)pLysS (36.1 mg/L and 788 μM), followed by 
tuner(DE3)pLacI (23.0 mg/L and 503 μM), and BL21(DE3)pLysS (14.0 mg/L and 306 μM) 
(Table 7).  
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Figure 41. Subdomain 1 purification using 6x-his-tag affinity chromatography. Protein was 
expressed in LB media at 30 oC overnight using three different cell strains. (A) 
BL21(DE3)pLysS, (B) Tuner(DE3)pLacI, and (C) Rosetta(DE3)pLysS.  Red boxes: protein 
formed a lower amount of insoluble aggregates in the cell pellet compared to protein expression 
at 37 oC.  
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Figure 42. Subdomain 1 final yields were affected by expression temperatures and cell strains.  
Soluble and insoluble fractions in the supernatant and in the cell pellet were compared 
using purification SDS gels and the respective fractions were calculated using ImageJ software 
(Figure 43). It was observed that soluble fractions were only 16% and 41% for 
BL21(DE3)pLysS and rosetta(DE3)pLysS respectively when the protein was expressed at 37 oC 
(Figure 43A). However, when the protein was expressed at 30 oC, soluble fractions for 
BL21(DE3)pLysS and rosetta(DE3)pLysS remarkably increased to 57% and 83% (Figure 43B). 
The cell strains that produced the higher percentages of insoluble aggregates were BL21(DE3) 
expressed at 37 oC with 92% in the insoluble form and tuner(DE3)pLacI at 30 oC with 85%. 
Tuner(DE3)pLacI was insoluble to a large extent due to overexpression of the protein resulting 
in production of inclusion bodies. Since this cell strain is IPTG dependent, protein expression 
was not regulated. On the other hand, better results were obtained with cell strains that had a 
pLysS plasmid because the cell strains that contained this plasmid allowed a tight and selective 
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expression. The results shown in Figure 43 confirmed that lower expression temperature 
enhanced protein solubility.   
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Figure 43. Expression temperature and cell strains affected subdomain 1 solubility. (A) 
Insoluble and soluble percentages when protein was expressed at 37 oC. (B) Insoluble and 
soluble percentages when protein was expressed at 30 oC overnight. Percentages were calculated 
using ImageJ software.  
Protein concentration was calculated using the extinction coefficient of subdomain 1 
(36,130 M-1 cm-1) and its UV-vis absorbance at 280 nm. 
5.3.3 Subdomain 2 expression and purification 
The best expression and purification conditions used for subdomain 1 were used to 
express subdomain 2. This protein was therefore successfully expressed in E. coli 
rosetta(DE3)pLysS at a temperature of 30 oC overnight (Figure 44). Subdomain 2 molecular 
weight is ~20 kDa and a clear band can be observed close to the 24 kDa mark. Expressed protein 
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was further purified using 6x-his-tag affinity chromatography and the final yield was 7 mg/L and 
a concentration of 363 μM in ~2 mL (Figure 44).    
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Figure 44. Subdomain 2 expression and purification using 6x-his-tag affinity chromatography. 
(LB media, rosetta(DE3)pLysS, 30 oC overnight expression).  
5.3.4 Subdomain 1 and 2 expression in 15N labeled minimal media 
Additional efforts were made to express and purify subdomain 1 and 2 in 15N labeled 
minimal media. These two engineered proteins were expressed in E. coli BL21(DE3)pLysS, 
rosetta(DE3)pLysS, and tuner(DE3)pLacI. The best cell strain that expressed these proteins with 
the least amount of insoluble aggregates in C/P was tuner(DE3)pLacI for both of these proteins 
(see red boxes in Figure 45A). The SDS gel clearly shows that the proteins were expressed and 
that even though a large amount of protein was present in the C/P a significant amount of protein 
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was in the Sup or soluble form. Additionally, these proteins were purified using 6x-his-tag 
affinity chromatography and the SDS purification gel for subdomain 1 can be observed in Figure 
45B. 
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Figure 45. (A) Subdomain 1 and subdomain 2 expression using 15N labeled minimal media 
(tuner(DE3)pLacI) and cell disruption using French press. (B) Subdomain 1 purification using 
6x-his-tag affinity chromatography.  
5.3.5 Subdomain 3 expression optimization 
Four cell strains at different temperatures were tested: rosetta(DE3)pLysS at 30 oC 
overnight, BL21(DE3) at 37 oC, BL21(DE3)pLysS at 30 oC overnight, and tuner(DE3)pLacI at 
37 oC in order to express this protein. The optimum expression conditions used for subdomain 1 
and 2 did not express subdomain 3. One possible reason is that this protein has four more 
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cysteines and these residues could cause folding problems. This protein was only successfully 
expressed in tuner(DE3)pLacI at an expression temperature of 37 oC and 1 mL/L IPTG was used 
for induction (Figure 46). This protein was not expressed using any other of the tested cells 
strains (Figure 46).  
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Figure 46. Subdomain 3 expression optimization using four cell strains and two temperatures.  
Protein was expressed at 37 oC in LB media.  
5.3.6 Subdomain 3 purification optimization 
Subdomain 3 was purified at first using His-tag affinity chromatography but the collected 
fractions contained a low amount of pure protein because most of the protein was in the pellet 
forming insoluble aggregates after the cell was disrupted using French press (Figure 47A). The 
pellet containing the protein was subsequently solubilized and completely unfolded using 8 M 
urea then refolded by gradually removing urea. Therefore, the 8 M urea solution was diluted to 4 
M urea, dialyzed in 2 M urea, and then dialyzed in 10 mM Tris-HCl buffer, pH 7.4. The protein 
was then identified in the Sup after it was treated with urea (Figure 47A). The Sup containing the 
soluble and refolded protein was further purified using 6x-his-tag affinity chromatography 
(Figure 47B). Relevant fractions from the FPLC were collected (fractions 9 to 19), dialyzed in 
10 mM Tris-HCL buffer pH 7.4, and concentrated down to ~2 mL. The calculated final 
71 
concentration using UV-visible spectroscopy was 300 μM in a 2 mL volume and the final yield 
was 7 mg/L. 
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Figure 47. Subdomain 3 purification. SDS gels, (A) Subdomain 3 purification from insoluble 
aggregates. Pellet (P) and supernatant (sup) before and after refolding. Red box: protein is now 
in soluble supernatant form. (B) Subdomain 3 collected fractions after affinity chromatography.  
5.3.7 Structural and conformational analyses for subdomains of the CaSR 
Secondary and tertiary structures of the three subdomains and their conformational 
changes upon Ca2+ addition were investigated by Dr. Yun Huang using CD spectroscopy and 
intrinsic tryptophan (Trp) fluorescence (details can be observed in her thesis dissertation) [38]. 
The three subdomains exhibited typical helical secondary structure with negative signals at 208 
nm and 222 nm (Figure 48A) as it was predicted by their model structures (Figure 48B). The 
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model structures of subdomain 1 and 2 clearly show a high globular helical content, however a 
lower number of helices was observed in subdomain 3 and that explains why subdomain 3 
exhibited a slightly different CD spectrum compared to the other subdomains (Figure 48B). 
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Figure 48. Structural analysis of subdomains using CD spectroscopy (A) Subdomains exhibited 
typical helical secondary structures. (B) Predicted model structures for each subdomain 
exhibiting high helical content. 
Subdomains’ conformational changes upon Ca2+ addition were investigated using CD 
spectroscopy and Trp fluorescence. CD spectra changes were observed for subdomain 1 and 3 
after addition of saturating amounts of Ca2+ indicating that the secondary structure for these two 
subdomains is changing to a more helical form. Additional changes were observed for Trp 
fluorescence spectra indicating a change in the tertiary structure; this change was particularly 
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evident for subdomain 1 since an increase in the Trp fluorescence intensity was observed (Figure 
49).  
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Figure 49. Conformational changes of the subdomains upon Ca2+ binding. (A) Far UV-CD 
spectra. (B) Trp fluorescence spectra [10]. 
5.3.8  Subdomain 1 metal-binding process 
An additional metal-binding study that includes a Tb3+-luminescence resonance energy 
transfer was performed by Dr. Yun Huang (details can be observed in her thesis dissertation) 
[38]. This metal-binding process confirmed that subdomain 1 exhibited a biphasic binding 
process as can be observed in Tb3+-titration curve (Figure 50). This curve clearly shows that at 
least 2 metal-binding processes or components are occurring in subdomain 1. The first 
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component was attributed to site 1 and the second component corresponds to site 3 as it was 
concluded by Dr. Yun Huang [10].   
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Figure 50. Tb3+ titration curve for subdomain 1. Subdomain 1 exhibited at least two metal-
binding processes [38]. 
5.3.9 Extracellular domain (ECD) of the CaSR 
The ECD of the CaSR is a huge domain with a molecular weight of ~73 kDa and this 
protein has not been expressed before in E. coli. This protein’s expression and purification has 
been challenging due to its size, its extracellular environment, and the presence of ~20 cysteine 
residues in its original sequence and a rich cysteine region that connects the ECD with the 
7TMD of the CaSR [51] (Figure 51). We have predicted five Ca2+-binding sites located on the 
ECD and we have divided the ECD into three subdomains. The expression and purification of 
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the ECD is essential in order to further investigate how the three subdomains and their respective 
Ca2+-binding sites interact with each other.  
 
Figure 51. ECD of the CaSR contains 20 cysteine residues and a cysteine-rich region of 9 
cysteine residues (pink box) that connects the ECD with a 7 TMD [51].  
The following data show recent efforts made in order to express and purify this protein. It 
is important to mention that these are the best conditions that have been achieved to date, but 
further optimization procedures are being evaluated. The most recent purified protein using the 
best conditions up to this point showed low stability and degradation. 
5.3.9.1 ECD expression optimization 
ECD was cloned in a pRSETa vector containing a 6x-his-tag region in order to be purified 
using affinity chromatography in the same manner as its subdomains. Since the molecular weight 
of this protein is close to 73 kDa it was necessary to use 8% SDS gels in order to observe its 
purity and molecular weight band using gel electrophoresis.  
This protein was first expressed in E. coli rosetta-gami(DE3)pLysS at 37 oC. Cells were 
growing at a very slow rate but they were still collected the same day after induction (3 h AI) 
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(Figure 52). Additional efforts were made to express this protein at 3 different temperatures 25 
oC, 30 oC, and 37 oC overnight in order to determine if the temperature and expression time 
could affect the ECD expression. Temperature and expression time indeed affected this protein’s 
expression because ECD was not expressed at low temperatures (25 oC and 30 oC) but it was 
expressed at 37 oC both during a single day and overnight expression (Figure 52). The SDS gel 
clearly shows that the protein was better expressed at 37 oC overnight. The same conditions were 
utilized to express the ECD in tuner(DE3)pLacI at 37 oC overnight but this cell strain expressed 
other proteins besides ECD. OrigamiB(DE3)pLysS at 30 oC overnight was also tested and 
actually a more pronounced expression band was observed in origamiB(DE3)pLysS when 
compared with the other two cell strains (Figure 53A). Additionally, origamiB(DE3)pLysS 
obtained the higher intensity change AI/BI followed by rosetta-gami(DE3)pLysS and 
tuner(DE3)pLacI (Figure 53B). Therefore, a higher expression level was observed with origami-
B(DE3)pLysS and rosetta-gami(DE3)pLysS because these two cell strains contain mutations in 
the thioredoxin and glutathione reductase facilitating disulfide bond formation in the cytoplasm. 
3 h             3 h  O/N           3 h  O/N            3 h  O/N
BI     AI     BI        AI          BI       AI          BI    AI
37 oC 37 oC 30 oC 25 oC
kDa
68―
24―
 
Figure 52. ECD of the CaSR expression at three temperatures (Vector: pRSETa, LB media). 
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Figure 53. ECD of the CaSR expression. (A) Expression using different cell strains: 
tuner(DE3)pLacI, rosetta-gami(DE3)pLysS, and origamiB(DE3)pLysS at 37 oC and 30 oC 
overnight (Vector: pRSETa, LB media). (B) Intensity change AI/BI for ECD expression using 
different cell strains.  
5.3.9.2 ECD purification optimization 
Expressed protein was further purified using 6x-his-tag affinity chromatography. A few 
changes were made to the protocol used for the subdomains purification because when the same 
protocol was used for ECD purification a significant amount of protein degraded. Two major 
changes were therefore made to the usual 6x-his-tag affinity chromatography purification. The 
first change was dissolving the expression pellet in lysis buffer with two tablets of protease 
inhibitor. This step was done in order to prevent degradation of the protein by proteases. The 
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second change was that the initial imidazole concentration of the solution before it was injected 
into the FPLC was increased from 20 mM to 50 mM. This step was done in order to increase the 
binding competition between imidazole and protein so that the purity could be increased.  
Protein was purified using affinity chromatography and the best results were obtained 
when the protein was expressed in rosetta-gami(DE3)pLysS at 37 oC overnight (Figure 54A). 
However, degradation was observed and the presence of insoluble aggregates in the C/P was also 
evident in all three cases (Figure 54A-C). Collected fractions from the His-tag column were 
dialyzed in 10 mM Tris-HCl buffer, pH 7.4 and consequently concentrated down to ~2 mL. The 
final concentration was calculated using UV-vis spectroscopy, protein’s absorbance at 280 nm, 
and its extinction coefficient which is 110,300 M-1 cm-1. The final yields were 12.7 mg/L, 3.9 
mg/L, and 6.7 mg/L for rosetta-gami(DE3)pLysS, tuner(DE3)pLacI, and origamiB(DE3)pLysS 
respectively (Table 8). Optimum purification conditions for this protein are still under 
investigation but the best conditions to date were observed with rosetta-gami and origamiB since 
they facilitate disulfide-bond formation in the cytoplasm.  
Table 8. ECD final yields when protein was expressed in different cell strains 
Cell strain Yield (mg/L)
Rosetta(DE3)pLysS 12.7
Tuner(DE3)pLacI 3.9
Origami-B(DE3)pLysS 6.7
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Figure 54. ECD of the CaSR purification using 6x-his-tag affinity chromatography. (A) Protein 
was expressed in E. coli rosetta-gami(DE3)pLysS, (B) tuner(DE3)pLacI, and (C) 
origamiB(DE3)pLysS.   
5.4 Summary 
Five predicted Ca2+-binding sites of the CaSR (sites 3 and 5) were grafted into CD2 and 
two out of those five were expressed in E. coli BL21(DE3) at 37 oC. Since these sites were 
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previously cloned in a pGEX-2T vector containing a GST-tag, further purification was 
performed using affinity and ion-exchange chromatography. The predicted Ca2+-binding sites 
were subjected to a series of experiments that confirmed that they are indeed Ca2+-binding sites 
of the CaSR.  
The ECD of the CaSR was cleaved into three subdomains that contained the predicted 
Ca2+-binding sites. Subdomain 1 was first expressed in E. coli BL21(DE3) using three different 
vectors: pGEX-2T, pET32a, and pRSETa. This protein formed insoluble aggregates in all three 
cases and for that reason additional efforts were made to optimize subdomain 1 expression and 
purification utilizing pRSETa vector. This protein was therefore expressed in four different cell 
strains and two temperatures. Expressed proteins were then purified using 6x-his-tag affinity 
chromatography in order to determine whether the protein formed insoluble aggregates after cell 
disruption. The best results were obtained when subdomain 1 was expressed in 
rosetta(DE3)pLyS at 30 oC overnight. Therefore, lower temperatures slowed down the protein 
expression allowing proper protein folding and increasing its solubility. 
The same expression and purification conditions were used to successfully express and 
purify subdomain 2. Therefore, subdomain 2 was also expressed in rosetta(DE3)pLysS at 30 oC 
overnight and purified using affinity chromatography.  
On the other hand, subdomain 3 was expressed using a different cell strain 
tuner(DE3)pLacI since it was not expressed in rosetta(DE3)pLysS, BL21(DE3), or 
BL21(DE3)pLysS. This protein was purified from insoluble aggregates by refolding the protein 
followed by affinity chromatography.  
All three subdomains were successfully purified with concentrations between 300 to 800 
μM in a volume of ~ 2 mL and yields between 7 to 36 mg/L (Table 7). Additional efforts have 
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been recently made to express and purify the ECD of the CaSR. The best results show that this 
protein was successfully expressed in E. coli rosetta-gami(DE3)pLysS at 37 oC overnight and 
origamiB(DE3)pLysS at 30 oC overnight. This protein was purified using affinity 6x-his-tag 
chromatography. Additional efforts have been made in order to optimize the expression and 
purification of the ECD of the CaSR since this protein has shown low stability and 
concentrations due to its size and presence of a high number of cysteine residues.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
82 
6. THE DESIGN APPROACH: PROTEIN PURIFICATION FROM 
INCLUSION BODIES 
6.1 Introduction 
The purpose of the design approach is to use a computer algorithm to generate potential 
Ca2+-binding sites and then incorporate those sites into a chosen host protein (CD2) using site-
directed mutagenesis [15]. The advantage of this approach is that it will allow us to understand 
the factors that contribute to Ca2+ binding by investigating the relationship between net charges 
in the coordination sphere and the Ca2+-binding affinities [13, 15]. It is important to mention that 
the electrostatic nature of Ca2+ binding is highly affected by charged residues, binding geometry, 
and protein environment [59].  
Two proteins were designed in order to study the effect of local charges on metal-binding 
affinity, CD2.6D15 and CD2.7E15. The first one (CD2.6D15) has three negatively charged 
ligands and contains two mutations (N15D and N17D) and two natural residues as ligands (N60 
and D62) as it can be observed in the NMR structure of this engineered protein (Figure 55A) 
[59]. The second one (CD27E15) has five negatively-charged ligands, three mutations (N15E, 
L58D, and K64D) and two natural residues as ligands (E56 and D62) as observed in the model 
structure shown in Figure 55B [59]. Previous studies have concluded that the incorporation of 
these Ca2+ ligands into the host protein did not reveal global conformational changes in the 
designed proteins [59]. It was also concluded that CD2.7E15 had a 12 to 14-fold increase in the 
binding affinity for Ca2+, Tb3+, and La3+ compared to CD2.6D15 [59]. However, the localized 
charges in CD2.7E15 decreased the host protein’s thermal stability (Tm) from 61 oC to 41 oC  
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[59]. The designed approach can be therefore used to further study Ca2+ signaling and binding 
affinities properties. 
A B
 
Figure 55. (A) NMR structure of CD2.6D15. (B) Model structure of CD2.7E15. Pictures 
generated using PyMol (DeLano Scientific LLC) [59].  
CD2.7E15 was initially expressed in E. coli as a fusion GST-tag protein but its expression 
and purification levels were very low. Therefore, in order to improve this protein’s expression 
and purification this protein has been expressed and purified as a tag-less protein. Also, a series 
of newly-designed proteins have been created using the design approach for the purpose of 
creating contrast agents in cancer cell targeting. One of these designed proteins is CD2.7E15.52I 
containing a bombesin insertion (Glu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-
Met-NH2). Bombesin possesses a high affinity for the gastrin releasing peptide which is over 
expressed on different types of cancer cells [60]. Bombesin addition can therefore enrich the 
environment in which the designed protein contrast agent moves and in that way increase the 
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intensity and targeting in tumor detection. This protein did not contain a tag and for that reason it 
was necessary to develop new and optimized conditions to express and purify tag-less protein.  
6.2 Designed proteins as MRI contrast agents 
Magnetic resonance imaging (MRI) is a noninvasive technique that provides three-
dimensional images of anatomic structures and that are often used as contrast agents between 
healthy and pathological tissues [61, 62]. Gadolinium (Gd3+) chelators are commonly-used 
contrast agents and recent studies have determined that CD2.6D15 and CD2.7E15 have a high 
affinity for Gd3+ and they can be therefore used as Gd3+ chelators in magnetic resonance imaging 
(MRI) [63]. These protein-based MRI contrast agents have shown that metal-binding selectivity 
and affinity can be improved by utilizing the design approach [63]. 
6.3 Results and discussion 
6.3.1 CD2.7E15.52I expression optimization 
Engineered proteins that were created using a designed approach (CD2.7E15 and variants) 
has been previously expressed and purified using affinity chromatography but typically exhibited 
a common problem with low yields. Protein purification from inclusion bodies was an excellent 
option to further optimize the purification and in that way improve the proteins’ yield at a low 
cost. This technique advantageously reduces protein degradation and improves proper refolding 
which typically enhances protein’s activity.  
CD2.7E15.52insertion (CD2.7E15.52I) was expressed in E. coli as a fusion engineered 
protein in a pET20b vector. Initial expression of this protein was attempted using four cell strains 
BL21, BL21(DE3), BL21(DE3)pLysS, and tuner(pLacI), but only BL21(DE3)pLysS and 
tuner(DE3)pLacI produced expression, with the latter resulting in the best expression. This 
protein was subsequently expressed at two temperatures 37 oC and 30 oC overnight in order to 
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further optimize CD2.7E15.52I expression. The expression growth curve shows that the cell 
culture reached an OD of ~1.5 when it was expressed at 37 oC (8 h expression) and it reached an 
OD of ~ 2.0 when it was expressed at 30 oC (16 h expression) (Figure 56A). The SDS gels 
(Figure 56B) show that a thicker expression band is observed when the protein is expressed at 30 
oC overnight compared to that observed when the protein was expressed at 37 oC. Therefore, 
lower temperatures, such as 30 oC increased the expression level. Tuner(DE3)pLacI is IPTG 
dependent and for that reason the IPTG concentration used for induction was also optimized. 
The best results were obtained when protein expression was induced with 500 μL IPTG per liter.   
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Figure 56. (A) CD2.7E15.52.Insertion growth curve at two different temperatures 37 oC (blue) 
30 oC (red). (Vector: pET20b, LB media, tuner(DE3)pLacI). (B) CD2.7E15.52.Insertion 
expression in E. coli at 37 oC (left) and 30 oC overnight (right).  
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6.3.2 CD2.7E15.52I purification 
This protein was purified using an 8 M urea refolding method followed by ion exchange 
chromatography. The purification SDS gels clearly show the refolding process step by step when 
the protein was expressed at 30 oC overnight (left) and at 37 oC (right) (Figure 57). The first two 
lines in both gels show the pellet (P) and the supernatant (Sup) after the cells were broken using 
French Press. It can be observed from the gel (Figure 57) that most of the protein is in the pellet 
form. The pellet was washed using a detergent (Titron X-100) in order to remove impurities 
present in the pellet, such as cell debris or remains. The following three lanes in each gels show 
the pellet and supernatant after the pellet was dissolved in 8 M urea and followed dilution in 4 M 
urea. It is evident that the protein was completely solubilized from the pellet to the supernatant 
form (Figure 57).  This SDS gels also show the supernatant after it was dialyzed in 10 mM Tris-
HCl buffer, pH 7.4. The purification produced better results when the protein was expressed at 
30 oC overnight.  
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Figure 57. CD2.7E15.52.Insertion purification using urea refolding method. Protein was 
expressed at 30 oC overnight (left). Protein was expressed at 37 oC (right). 
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Dialyzed sample was further purified using ion exchange chromatography. Protein 
concentration was calculated using the extinction coefficient of CD2.WT (11,700 M-1 cm-1) and 
its UV-vis absorbance at 280 nm. The final yield was ~20 mg/L. 
6.3.3 CD2.7E15  expression 
The same approach used to express CD2.7E15.52I was also implemented to express 
CD2.7E15. This protein was successfully expressed as a tag-less protein in E. coli 
tuner(DE3)pLacI at 30 oC overnight (Figure 58). The expression level was not as high as that 
observed for CD2.7E15.52I but it was enough to obtain pure protein. Another difference was that 
this protein expressed unknown proteins besides our targeted protein as a strong dark 
background was observed in the expression SDS gel. 
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Figure 58. CD2.7E15 expression in E. coli at 30 oC overnight (vector: pET20b, LB media, 
tuner(DE3)pLacI).  
6.3.4 CD2.7E15 purification 
The same approach used to purify CD2.7E15.52I was also implemented to purify 
CD2.7E15. The purification was therefore performed using an 8 M urea refolding method 
88 
(Figure 59).The first two lines show the pellet (P) and the supernatant (Sup) after the cells were 
broken using French Press. It can be observed (Figure 59)  that most of the protein is the pellet 
form. The pellet was washed using a detergent (Titron X-100) in order to remove impurities. The 
following three lanes in each gels show the pellet and supernatant after the pellet was dissolved 
in 8 M urea and then diluted to 4 M urea. It is clear that the protein was completely solubilized 
from the pellet to the supernatant form.  This SDS gel also shows the supernatant after it was 
dialyzed in 10 mM Tris-HCl buffer, pH 7.4. The purity of this protein was not as high as that 
observed for CD2.7E15.52I since a series of bands above that of our targeted protein were 
observed in the SDS expression and purification gel. Protein was further purified using ion 
exchange chromatography after it was dialyzed in 10 mM Tris-HCl buffer. The additional bands 
observed in Figure 59 were completely removed after ion exchange FPLC. Figure 60 illustrates 
the FPLC profile and SDS gel confirming the high purity of the purified protein.  
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Figure 59. CD2.7E15 purification using urea refolding method.  
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Figure 60. CD2.7E15 ion exchange chromatography and SDS gel showing the collected relative 
fractions from the FPLC.  
Protein concentration was calculated using the extinction coefficient of CD2.WT (11,700 
M-1 cm-1) and its UV-vis absorbance at 280 nm. The final yield was ~10mg/L.  
6.4  Summary 
The design approach allows the investigation of local charges and the factors that might 
contribute to Ca2+ binding. Two designed engineered proteins CD2.7E15.52I and CD2.7E15 
were successfully expressed in E. coli tuner(DE3)pLacI at 30 oC overnight. Tuner(DE3)pLacI 
have shown to form a high number of inclusion bodies during protein expression. This cell strain 
contains a mutation in lacY (lac permease) gene allowing over protein expression in the presence 
of a high IPTG concentration. Over protein expression therefore facilitates inclusion body 
formation and sometimes this is the only way to obtain protein. Protein expressed in inclusion 
bodies can be purified using refolding methods. These engineered proteins were actually purified 
from inclusion bodies utilizing a refolding strategy followed by ion exchange chromatography. 
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The final yields were ~20 mg/L for both engineered proteins but further expression and 
purification optimization procedures are still under investigation. These designed proteins have 
been used as protein-based MRI agents and they have been also used to perform metal-binding 
and affinity analyses.  
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7. FINAL CONCLUSIONS AND SIGNIFICANCE OF THIS THESIS 
Ca2+ is an essential element in living organisms since it regulates a great number of 
biological and cellular signaling pathways. Ca2+ concentrations in extracellular and intracellular 
environments are balanced and stabilized by a select group of Ca2+-binding proteins. This vital 
group of proteins usually has two or more Ca2+-binding sites that interact with each other upon 
Ca2+ binding. They are able to undergo conformational changes upon Ca2+-binding and these 
conformational changes are then translated into metabolic pathways. Additionally, they are able 
to sense intracellular and/or extracellular Ca2+ concentration changes or imbalances and take 
action in order to maintain a proper equilibrium in both environments.  
The investigation of Ca2+-binding sites is essential in order to understand the biochemical 
properties of Ca2+-binding proteins and further, to comprehend and determine the mechanisms 
behind this reciprocal Ca2+-protein interaction. Three approaches have been developed in Dr. 
Yang’s laboratory in order to study Ca2+-binding sites located in Ca2+-binding proteins. The 
basic principle of these approaches is the prediction of Ca2+-binding sites using computer 
algorithms, which provides a rational basis for grafting and/or designing them into host proteins. 
In the grafting approach, individual Ca2+-binding sites were inserted into host proteins (e.g. CD2 
or EGFP) in order obtain metal-binding affinities and site-specific properties of Ca2+-binding 
proteins. In the design approach, site-directed mutagenesis was used to design Ca2+-binding sites 
into host proteins.  This approach has permitted the investigation of factors that contribute to 
local Ca2+-binding and the relationship between net charges located in the coordination sphere of 
these sites. In the subdomain approach, Ca2+-binding proteins have been dissected into different 
subdomains containing 2-3 Ca2+-binding sites. This approach allowed the study of the interaction 
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between Ca2+-binding sites, their conformational changes, and cooperative interaction upon Ca2+ 
binding.  
A variety of techniques (e.g. CD, MS, NMR, metal-binding titrations, and X-ray 
crystallography) have been applied in order to test the predicted Ca2+-binding sites and to 
understand important properties and characteristics of Ca2+-binding proteins. The techniques 
used in these studies require high protein concentration and purity, and that is why expression 
and purification of engineered proteins play essential roles to further conduct those experiments. 
The chosen expression host for engineered protein production was E. coli. This is the most 
widely used bacterial host for protein expression, but sometimes expression and purification of 
engineered proteins can be very challenging because the insertion of foreign sequences into a 
host protein might result in stability and conformational changes that affect protein yield and 
purity. Other challenges include low expression levels, formation of inclusion bodies due to 
improper folding, and proteolytic degradation.  
In this thesis, the significance of expression and purification of engineered proteins as initial 
steps to further investigation of the properties of Ca2+-binding proteins is discussed with respect 
to optimization of expression and purification to obtain high protein yield and purity. Logically, 
further experimentation is limited by the availability of proteins of sufficient quality and 
quantity.  
In previous chapters, I have shown that expression and purification of engineered Ca2+-
binding proteins are highly influenced by a great number of factors, such as expression 
temperature, cell strains, vectors, and inducer concentrations. Additionally, there are an extended 
number of purification techniques and fusion technologies that can be employed to purify 
proteins based on the protein’s physiochemical properties, such as their isoelectric points, 
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molecular weights, polarity, and/or affinity to ligands. Thus, purification of engineered proteins 
was performed using different techniques depending upon their characteristics.  
Proteins engineered using a grafting approach in which an individual Ca2+-binding motif 
was inserted into CD2.D1 (CD2-WT, CD2.STIM1, CD2.STIM1.Mut, and CD2.RubCa) were 
expressed in E. coli BL21(DE3) at 37 oC and further purified by affinity chromatography since 
they contained a GST-tag, followed by ion-exchange chromatography. Additionally, another set 
of engineered proteins that had EGFP as the host protein (WT-EGFP and EGFP-172-III-172) 
were also expressed in E. coli BL21(DE3) but the expression temperature was reduced to 30 oC 
in order to increase chromophore formation. These proteins were purified using affinity 
chromatography since they contained a 6x-his-tag. The yields for these proteins were between 
20-70 mg/L (Chapter 3). 
CaM is an intracellular Ca2+-binding protein that was expressed in E. coli BL21(DE3) at 37 
oC in LB media and at 30 oC overnight in 15N labeled minimal media. A lower temperature was 
used for the minimal media because it required a longer incubation time since it contained fewer 
nutrients compared to LB media. CaM was purified using a phenyl-sepharose column and 
hydrophobic interaction chromatography, since this protein undergoes a conformational change 
upon Ca2+ binding that exposes hydrophobic patches to the surface. The final yields were 74.8 
mg/L and 57.8 mg/L when the proteins were expressed in LB and 15N labeled minimal media 
respectively. CaM 15N labeled protein was further utilized to perform NMR studies (Chapter 4).  
The CaSR is another important Ca2+-binding protein that has been studied. Five Ca2+-
binding sites in the ECD of this receptor were predicted and two of these sites (3 and 5) were 
grafted into CD2.D1. These two sites were also expressed in E. coli BL21(DE3) at 37 oC and 
purified using GST-tag affinity and ion exchange chromatography. An additional set of mutants 
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were also expressed and purified using the same approaches. The final yields for these proteins 
were ~7 mg/L. Metal-binding studies performed by Dr. Huang have determined the metal-
binding affinity of these two Ca2+-binding sites (Chapter 5). 
A subdomain approach was also utilized to study the CaSR in which the ECD of this 
receptor was dissected into three subdomains containing the predicted Ca2+-binding sites. These 
proteins presented low expression levels, were highly insoluble, and/or were expressed as 
inclusion bodies. We first attempted to optimize the expression and purification of subdomain 1 
by utilizing different vectors, E. coli cell strains, and temperatures. Subdomain 1 expression 
levels and solubility were highly enhanced when the protein was expressed at 30 oC and when 
rosetta(DE3)pLysS was used as the cell strain. These conditions were utilized to express and 
purify subdomain 2. Subdomain 3 was expressed in E. coli tuner(DE3)pLysS as inclusion bodies 
and they were purified using a refolding technique followed by affinity chromatography. The 
final yields were 7-36 mg/L. Additional efforts have been made to express and purify the ECD of 
the CaSR. This 73 kDa protein contains ~20 cysteine residues that have highly influenced 
protein expression and purification. The best cell strains that expressed this protein were rosetta-
gami(DE3)pLysS and origamiB(DE3)pLysS since these strains contain mutation in thioredoxin 
and glutathione reductase genes facilitating disulfide bond formation as well as proper protein 
folding. The optimum expression and purification conditions are still under investigation since 
the protein presented high levels of degradation and precipitation. Further experiments 
performed by Dr. Yun Huang (e.g. CD and trp fluorescence) have shown that a conformational 
change is observed when saturating Ca2+ concentrations were added to the proteins. 
Additionally, metal-binding studies have shown that subdomain 1 exhibited a biphasic binding 
mechanism (Chapter 5). 
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Another set of engineered proteins (CD2.7E15 and CD2.7E15.52I) were created utilizing a 
design approach in which Ca2+-binding sites were designed in CD2.D1 using site-directed 
mutagenesis. These proteins were expressed as tag-less proteins in E. coli tuner(DE3)pLacI as 
inclusion bodies and further purified using a refolding strategy followed by ion exchange 
chromatography. Protein expression and purification from inclusion bodies might be an efficient 
way to obtain active proteins with high yields and purity. CD2.7E15.52I has been used as a MRI 
contrast agent for tumor targeting (Chapter 6).  
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